Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix structural constituent	RELN LAMA1 OTOL1 NID1 HSPG2 NID2 COL12A1 VWF ABI3BP TNC EFEMP2 LAMA2 LAMA4 TECTA MMRN1	5.37e-09	188	231	15	GO:0005201
GeneOntologyMolecularFunction	calcium ion binding	ENPP3 SRI DGKB OTOL1 TUBB4A CDH20 NRXN1 NID1 PLCG1 ADGRL3 HSPG2 NID2 FAT4 DSC2 PCDHGA10 EFEMP2 PKD2L1 GRM7 MMRN1 DCHS1 CD69 CDH10 CDH12	2.11e-05	749	231	23	GO:0005509
GeneOntologyMolecularFunction	protein tyrosine phosphatase activity	EYA4 EYA2 PTPN4 PTPN9 PTPN12 PTPRQ TPTE2 PTPRT	2.63e-05	103	231	8	GO:0004725
GeneOntologyMolecularFunction	cell adhesion molecule binding	ADAM18 ITGA4 LILRB1 CDH20 NRXN1 NRXN2 CNTN5 PLEC LILRA1 VWF DSC2 TNC GLOD4 ADAMTS8 PTPRT DCHS1 ADAM2 CDH10 CDH12	7.39e-05	599	231	19	GO:0050839
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor	GLUD1 GLUD2	1.33e-04	2	231	2	GO:0016639
GeneOntologyMolecularFunction	glutamate dehydrogenase [NAD(P)+] activity	GLUD1 GLUD2	1.33e-04	2	231	2	GO:0004353
GeneOntologyMolecularFunction	glutamate dehydrogenase (NAD+) activity	GLUD1 GLUD2	1.33e-04	2	231	2	GO:0004352
GeneOntologyMolecularFunction	glutamate dehydrogenase (NADP+) activity	GLUD1 GLUD2	1.33e-04	2	231	2	GO:0004354
GeneOntologyMolecularFunction	inhibitory MHC class I receptor activity	LILRB1 LILRA1 LILRA3	3.11e-04	12	231	3	GO:0032396
GeneOntologyMolecularFunction	non-membrane spanning protein tyrosine phosphatase activity	PTPN4 PTPN9 PTPN12	3.11e-04	12	231	3	GO:0004726
GeneOntologyMolecularFunction	collagen binding	NID1 USH2A HSPG2 NID2 VWF ABI3BP	3.54e-04	81	231	6	GO:0005518
GeneOntologyMolecularFunction	calcium channel regulator activity	SRI PACSIN3 NRXN1 NRXN2 GRM7	3.96e-04	54	231	5	GO:0005246
GeneOntologyMolecularFunction	metalloendopeptidase activity	ZMPSTE24 ADAM18 PHEX ADAMTS4 ADAMTS8 ADAM5 ADAM2	4.98e-04	120	231	7	GO:0004222
GeneOntologyMolecularFunction	structural molecule activity	RELN EPPK1 LAMA1 OTOL1 TUBB4A NID1 ACTL9 PLEC HSPG2 NID2 COL12A1 VWF ABI3BP TNC EFEMP2 LAMA2 LAMA4 TECTA ACTR3 MMRN1 IGF1R MYBPC1	6.97e-04	891	231	22	GO:0005198
GeneOntologyMolecularFunction	immunoglobulin binding	LILRB1 PIGR LILRA1 VWF	7.69e-04	36	231	4	GO:0019865
GeneOntologyMolecularFunction	group III metabotropic glutamate receptor activity	GRM6 GRM7	7.87e-04	4	231	2	GO:0001642
GeneOntologyMolecularFunction	carbohydrate binding	GALM NOMO2 AGL ADGRL3 SI SLC2A5 NOMO1 P3H2 GYS1 CD69 NOMO3	1.02e-03	310	231	11	GO:0030246
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH6 DNAH2 DNAH1	1.10e-03	18	231	3	GO:0008569
GeneOntologyMolecularFunction	MHC class I receptor activity	LILRB1 LILRA1 LILRA3	1.10e-03	18	231	3	GO:0032393
GeneOntologyMolecularFunction	neuroligin family protein binding	NRXN1 NRXN2	1.30e-03	5	231	2	GO:0097109
GeneOntologyMolecularFunction	HLA-A specific inhibitory MHC class I receptor activity	LILRB1 LILRA1	1.30e-03	5	231	2	GO:0030107
GeneOntologyMolecularFunction	beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity	B4GALT1 WDFY3	1.30e-03	5	231	2	GO:0003831
GeneOntologyBiologicalProcess	neuron projection development	EPHB6 RELN MYH10 LAMA1 ITGA4 CUL7 DCX HOXA1 STK11 NEK3 PRDM8 PTPN9 SEMA6D PLPPR4 NRXN1 NEGR1 CNTN5 ARHGAP44 FES IQSEC1 ACTL9 HSPG2 FAT4 SFRP1 B4GAT1 ABI3BP TNC LAMA2 CRTC1 TECTA GRM7 ACTR3 IGF1R ARSB SS18L1 SLITRK5 FYN PAQR3 SEZ6	9.16e-09	1285	229	39	GO:0031175
GeneOntologyBiologicalProcess	cell junction organization	RELN MYH10 CACNA2D2 DGKB CSMD2 DCX CDH20 LDB1 PLPPR4 NRXN1 NRXN2 NEGR1 CNTN5 ARHGAP44 IQSEC1 ACTL9 PLEC ADGRL3 TBX5 SFRP1 ABI3BP TNC NBEA GRM6 ACTR3 PTPRT IGF1R SLITRK5 ELAVL2 FYN CDH10 CDH12 SEZ6	1.10e-08	974	229	33	GO:0034330
GeneOntologyBiologicalProcess	synapse organization	RELN MYH10 CACNA2D2 DGKB CSMD2 DCX PLPPR4 NRXN1 NRXN2 NEGR1 CNTN5 ARHGAP44 IQSEC1 ACTL9 ADGRL3 ABI3BP TNC NBEA GRM6 ACTR3 PTPRT IGF1R SLITRK5 ELAVL2 FYN CDH10 SEZ6	1.25e-08	685	229	27	GO:0050808
GeneOntologyBiologicalProcess	cell morphogenesis	EPHB6 RELN MYH10 ZMPSTE24 LAMA1 ITGA4 CUL7 DCX HOXA1 STK11 NEK3 PRDM8 CDH20 SEMA6D PLPPR4 NRXN1 NEGR1 CNTN5 ARHGAP44 PTPRQ FES ACTL9 PLEC DNMBP HSPG2 B4GAT1 ABI3BP LAMA2 TECTA ACTR3 IGF1R SS18L1 SLITRK5 FYN CDH10 CDH12	4.39e-08	1194	229	36	GO:0000902
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	EPHB6 RELN MYH10 LAMA1 ITGA4 CUL7 DCX HOXA1 STK11 PRDM8 SEMA6D PLPPR4 NRXN1 CNTN5 ARHGAP44 PTPRQ ACTL9 HSPG2 B4GAT1 ABI3BP LAMA2 TECTA ACTR3 IGF1R SS18L1 SLITRK5 FYN	7.64e-08	748	229	27	GO:0048667
GeneOntologyBiologicalProcess	neuron development	EPHB6 RELN MYH10 LAMA1 ITGA4 CUL7 DCX HOXA1 STK11 NEK3 PRDM8 PTPN9 SEMA6D PLPPR4 NRXN1 NEGR1 CNTN5 ARHGAP44 PTPRQ FES IQSEC1 ACTL9 HSPG2 FAT4 SFRP1 B4GAT1 ABI3BP TNC LAMA2 CRTC1 TECTA GRM7 ACTR3 IGF1R ARSB SS18L1 SLITRK5 FYN PAQR3 SEZ6	9.97e-08	1463	229	40	GO:0048666
GeneOntologyBiologicalProcess	neuron projection morphogenesis	EPHB6 RELN MYH10 LAMA1 ITGA4 CUL7 DCX HOXA1 STK11 NEK3 PRDM8 SEMA6D PLPPR4 NRXN1 NEGR1 CNTN5 ARHGAP44 ACTL9 HSPG2 B4GAT1 ABI3BP LAMA2 ACTR3 IGF1R SS18L1 SLITRK5 FYN	3.06e-07	802	229	27	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	EPHB6 RELN MYH10 LAMA1 ITGA4 CUL7 DCX HOXA1 STK11 NEK3 PRDM8 SEMA6D PLPPR4 NRXN1 NEGR1 CNTN5 ARHGAP44 ACTL9 HSPG2 B4GAT1 ABI3BP LAMA2 ACTR3 IGF1R SS18L1 SLITRK5 FYN	4.62e-07	819	229	27	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	EPHB6 RELN MYH10 LAMA1 ITGA4 CUL7 DCX HOXA1 STK11 NEK3 PRDM8 SEMA6D PLPPR4 NRXN1 NEGR1 CNTN5 ARHGAP44 ACTL9 HSPG2 B4GAT1 ABI3BP LAMA2 ACTR3 IGF1R SS18L1 SLITRK5 FYN	5.45e-07	826	229	27	GO:0048858
GeneOntologyBiologicalProcess	axon development	EPHB6 RELN MYH10 LAMA1 ITGA4 DCX HOXA1 STK11 PRDM8 SEMA6D PLPPR4 NRXN1 CNTN5 ACTL9 HSPG2 B4GAT1 TNC LAMA2 GRM7 ACTR3 IGF1R SLITRK5 FYN	8.54e-07	642	229	23	GO:0061564
GeneOntologyBiologicalProcess	axonogenesis	EPHB6 RELN MYH10 LAMA1 ITGA4 DCX HOXA1 STK11 PRDM8 SEMA6D PLPPR4 NRXN1 CNTN5 ACTL9 HSPG2 B4GAT1 LAMA2 ACTR3 IGF1R SLITRK5 FYN	1.51e-06	566	229	21	GO:0007409
GeneOntologyBiologicalProcess	cell junction assembly	RELN CSMD2 DCX CDH20 LDB1 NRXN1 NRXN2 NEGR1 CNTN5 IQSEC1 PLEC ADGRL3 TBX5 SFRP1 ABI3BP GRM6 ACTR3 SLITRK5 ELAVL2 CDH10 CDH12	1.64e-06	569	229	21	GO:0034329
GeneOntologyBiologicalProcess	regulation of synapse organization	RELN MYH10 DGKB DCX PLPPR4 NRXN1 NRXN2 NEGR1 ARHGAP44 IQSEC1 ADGRL3 ABI3BP ACTR3 PTPRT SLITRK5 ELAVL2 FYN	1.67e-06	387	229	17	GO:0050807
GeneOntologyBiologicalProcess	regulation of synapse structure or activity	RELN MYH10 DGKB DCX PLPPR4 NRXN1 NRXN2 NEGR1 ARHGAP44 IQSEC1 ADGRL3 ABI3BP ACTR3 PTPRT SLITRK5 ELAVL2 FYN	2.21e-06	395	229	17	GO:0050803
GeneOntologyBiologicalProcess	postsynapse organization	RELN MYH10 DGKB CSMD2 DCX PLPPR4 NRXN1 NRXN2 ARHGAP44 ACTL9 ADGRL3 ABI3BP ACTR3 IGF1R FYN	2.41e-06	313	229	15	GO:0099173
GeneOntologyBiologicalProcess	head development	RELN MYH10 SRD5A2 ITGA4 DCX HOXA1 PRDM8 LDB1 SEMA6D NRXN1 NEGR1 CNTN5 GLUD1 SOX14 HSPG2 FAT4 SFRP1 AK8 IGF1R ARSB BARHL1 SLITRK5 PRDM13 MAPK1 MAPK3 FYN SEZ6	4.10e-06	919	229	27	GO:0060322
GeneOntologyBiologicalProcess	synapse assembly	RELN CSMD2 DCX NRXN1 NRXN2 NEGR1 CNTN5 IQSEC1 ADGRL3 ABI3BP GRM6 ACTR3 SLITRK5 ELAVL2	9.60e-06	308	229	14	GO:0007416
GeneOntologyBiologicalProcess	regulation of neuron projection development	RELN CUL7 DCX STK11 PTPN9 SEMA6D NRXN1 NEGR1 ARHGAP44 FES SFRP1 ABI3BP CRTC1 ACTR3 IGF1R ARSB SS18L1 FYN PAQR3 SEZ6	1.75e-05	612	229	20	GO:0010975
GeneOntologyBiologicalProcess	postsynaptic density assembly	RELN CSMD2 NRXN1 NRXN2 ABI3BP	3.46e-05	34	229	5	GO:0097107
GeneOntologyBiologicalProcess	regulation of postsynapse organization	RELN DGKB DCX PLPPR4 NRXN1 NRXN2 ARHGAP44 ABI3BP ACTR3 FYN	4.35e-05	185	229	10	GO:0099175
GeneOntologyBiologicalProcess	postsynaptic density organization	RELN CSMD2 NRXN1 NRXN2 ADGRL3 ABI3BP	4.38e-05	58	229	6	GO:0097106
GeneOntologyBiologicalProcess	regulation of cell junction assembly	DCX LDB1 NRXN1 NRXN2 NEGR1 IQSEC1 ADGRL3 TBX5 SFRP1 ABI3BP ACTR3 SLITRK5 ELAVL2	4.48e-05	309	229	13	GO:1901888
GeneOntologyBiologicalProcess	regulation of skeletal muscle fiber differentiation	HDAC9 HDAC5 RBM24	4.57e-05	7	229	3	GO:1902809
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	ITGA4 CDH20 NRXN1 CNTN5 ADGRL3 FAT4 DSC2 PCDHGA10 PTPRT SLITRK5 DCHS1 CDH10 CDH12	5.10e-05	313	229	13	GO:0098742
GeneOntologyBiologicalProcess	modulation of chemical synaptic transmission	RELN CACNA2D2 DGKB LILRB1 PLPPR4 NRXN1 NRXN2 ARHGAP44 IQSEC1 PLCG1 LILRA1 LAMA2 CRTC1 GRM6 GRM7 IGF1R SLITRK5 MAPK1 MAPK3 FYN	5.41e-05	663	229	20	GO:0050804
GeneOntologyBiologicalProcess	regulation of trans-synaptic signaling	RELN CACNA2D2 DGKB LILRB1 PLPPR4 NRXN1 NRXN2 ARHGAP44 IQSEC1 PLCG1 LILRA1 LAMA2 CRTC1 GRM6 GRM7 IGF1R SLITRK5 MAPK1 MAPK3 FYN	5.52e-05	664	229	20	GO:0099177
GeneOntologyBiologicalProcess	toll-like receptor signaling pathway	ESR1 GPR108 HSPD1 BIRC2 BIRC3 CD36 TLR5	5.62e-05	88	229	7	GO:0002224
GeneOntologyBiologicalProcess	sensory perception of mechanical stimulus	EYA4 MYO7B HOXA1 CNTN5 PTPRQ SCN9A USH2A TECTA GRM7 BARHL1 FYN	7.54e-05	238	229	11	GO:0050954
GeneOntologyBiologicalProcess	dendrite morphogenesis	RELN CUL7 DCX STK11 ARHGAP44 ABI3BP ACTR3 SS18L1 SLITRK5 FYN	7.70e-05	198	229	10	GO:0048813
GeneOntologyBiologicalProcess	regulation of toll-like receptor signaling pathway	ESR1 GPR108 BIRC2 BIRC3 CD36	7.74e-05	40	229	5	GO:0034121
GeneOntologyBiologicalProcess	ear development	EYA4 OTOL1 HOXA1 PLPPR4 PTPRQ USH2A FOXI1 FAT4 TECTA DCHS1 MAPK1 MAPK3	8.72e-05	285	229	12	GO:0043583
GeneOntologyBiologicalProcess	axon guidance	EPHB6 RELN MYH10 LAMA1 HOXA1 SEMA6D NRXN1 CNTN5 HSPG2 B4GAT1 LAMA2 FYN	8.72e-05	285	229	12	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	EPHB6 RELN MYH10 LAMA1 HOXA1 SEMA6D NRXN1 CNTN5 HSPG2 B4GAT1 LAMA2 FYN	9.02e-05	286	229	12	GO:0097485
GeneOntologyBiologicalProcess	regulation of synapse assembly	DCX NRXN1 NRXN2 NEGR1 IQSEC1 ADGRL3 ABI3BP ACTR3 SLITRK5 ELAVL2	9.09e-05	202	229	10	GO:0051963
GeneOntologyBiologicalProcess	brain development	RELN MYH10 SRD5A2 DCX HOXA1 PRDM8 LDB1 SEMA6D NRXN1 NEGR1 CNTN5 GLUD1 SOX14 HSPG2 FAT4 SFRP1 AK8 IGF1R BARHL1 SLITRK5 PRDM13 FYN SEZ6	9.15e-05	859	229	23	GO:0007420
GeneOntologyBiologicalProcess	dendrite development	RELN CUL7 DCX STK11 ARHGAP44 IQSEC1 ABI3BP CRTC1 ACTR3 SS18L1 SLITRK5 FYN SEZ6	1.01e-04	335	229	13	GO:0016358
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO2 NOMO1 NOMO3	1.08e-04	9	229	3	GO:0160063
GeneOntologyBiologicalProcess	postsynaptic specialization assembly	RELN CSMD2 NRXN1 NRXN2 ABI3BP	1.23e-04	44	229	5	GO:0098698
GeneOntologyBiologicalProcess	postsynaptic specialization organization	RELN CSMD2 NRXN1 NRXN2 ADGRL3 ABI3BP	1.38e-04	71	229	6	GO:0099084
GeneOntologyBiologicalProcess	circulatory system development	HDAC9 MYH10 ZMPSTE24 LAMA1 SRI ITGA4 CUL7 F3 B4GALT1 HOXA1 GREB1L STK11 NRXN1 FES PLCG1 PLEC TBX5 HSPG2 FAT4 SFRP1 HDAC5 ABI3BP EFEMP2 LAMA4 IGF1R CD36 GYS1 SLITRK5 DCHS1 MAPK1 MAPK3 RBM24	1.38e-04	1442	229	32	GO:0072359
GeneOntologyBiologicalProcess	excitatory synapse assembly	RELN CSMD2 NRXN1 NRXN2 ABI3BP	1.53e-04	46	229	5	GO:1904861
GeneOntologyBiologicalProcess	outer ear morphogenesis	HOXA1 MAPK1 MAPK3	1.53e-04	10	229	3	GO:0042473
GeneOntologyBiologicalProcess	central nervous system development	RELN MYH10 SRD5A2 DCX HOXA1 HOXB8 PRDM8 LDB1 SEMA6D NRXN1 NEGR1 CNTN5 GLUD1 SOX14 HSPG2 FAT4 SFRP1 ACTR3 AK8 IGF1R BARHL1 SLITRK5 PRDM13 MAPK1 MAPK3 FYN CLCF1 SEZ6	1.59e-04	1197	229	28	GO:0007417
GeneOntologyBiologicalProcess	cellular response to amyloid-beta	ITGA4 CACNA2D1 IGF1R CD36 FYN	2.07e-04	49	229	5	GO:1904646
GeneOntologyBiologicalProcess	regulation of basement membrane organization	LAMA1 NID1 LAMA2	2.09e-04	11	229	3	GO:0110011
GeneOntologyBiologicalProcess	postsynaptic density protein 95 clustering	RELN NRXN1 NRXN2	2.09e-04	11	229	3	GO:0097119
GeneOntologyBiologicalProcess	interleukin-10-mediated signaling pathway	LILRB1 LILRA1 LILRA3	2.09e-04	11	229	3	GO:0140105
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	CDH20 CNTN5 FAT4 DSC2 PCDHGA10 PTPRT DCHS1 CDH10 CDH12	2.52e-04	187	229	9	GO:0007156
GeneOntologyBiologicalProcess	calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	CDH20 NRXN1 DCHS1 CDH10 CDH12	3.00e-04	53	229	5	GO:0016339
GeneOntologyBiologicalProcess	activation of blood coagulation via clotting cascade	F3 VWF	3.65e-04	3	229	2	GO:0002543
GeneOntologyBiologicalProcess	sensory perception of sound	EYA4 MYO7B HOXA1 CNTN5 PTPRQ USH2A TECTA GRM7 BARHL1	3.83e-04	198	229	9	GO:0007605
GeneOntologyBiologicalProcess	male sex differentiation	ARID4B ADAM18 ESR1 SRD5A2 GREB1L SFRP1 ADAM5 ADAM2 CSMD1	3.97e-04	199	229	9	GO:0046661
GeneOntologyBiologicalProcess	positive regulation of integrin-mediated signaling pathway	LAMA1 NID1 LAMA2	4.49e-04	14	229	3	GO:2001046
GeneOntologyBiologicalProcess	prostate gland epithelium morphogenesis	ESR1 SFRP1 TNC IGF1R	4.70e-04	33	229	4	GO:0060740
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	RELN ENTR1 CUL7 DCX STK11 PTPN9 SEMA6D NRXN1 NEGR1 ARHGAP44 FES SFRP1 ABI3BP CRTC1 ACTR3 IGF1R ARSB SS18L1 FYN PAQR3 SEZ6	5.10e-04	846	229	21	GO:0120035
GeneOntologyBiologicalProcess	prostate gland morphogenesis	ESR1 SFRP1 TNC IGF1R	5.28e-04	34	229	4	GO:0060512
GeneOntologyBiologicalProcess	peptidyl-tyrosine dephosphorylation	PTPN9 PTPN12 PTPRQ PTPRT	5.28e-04	34	229	4	GO:0035335
GeneOntologyBiologicalProcess	inner ear development	EYA4 OTOL1 HOXA1 PLPPR4 PTPRQ USH2A FOXI1 FAT4 TECTA DCHS1	5.54e-04	253	229	10	GO:0048839
GeneOntologyBiologicalProcess	bundle of His cell to Purkinje myocyte communication	TBX5 CACNA2D1 DSC2	5.57e-04	15	229	3	GO:0086069
GeneOntologyBiologicalProcess	response to amyloid-beta	ITGA4 CACNA2D1 IGF1R CD36 FYN	5.79e-04	61	229	5	GO:1904645
GeneOntologyBiologicalProcess	postsynapse assembly	RELN CSMD2 DCX NRXN1 NRXN2 ABI3BP	5.98e-04	93	229	6	GO:0099068
GeneOntologyBiologicalProcess	prostate gland development	ESR1 STK11 SFRP1 TNC IGF1R	6.25e-04	62	229	5	GO:0030850
GeneOntologyBiologicalProcess	regulation of cell projection organization	RELN ENTR1 CUL7 DCX STK11 PTPN9 SEMA6D NRXN1 NEGR1 ARHGAP44 FES SFRP1 ABI3BP CRTC1 ACTR3 IGF1R ARSB SS18L1 FYN PAQR3 SEZ6	6.59e-04	863	229	21	GO:0031344
GeneOntologyBiologicalProcess	male gonad development	ARID4B ADAM18 ESR1 SRD5A2 SFRP1 ADAM5 ADAM2 CSMD1	6.66e-04	171	229	8	GO:0008584
GeneOntologyBiologicalProcess	G protein-coupled glutamate receptor signaling pathway	GRM6 GRM7 FYN	6.80e-04	16	229	3	GO:0007216
GeneOntologyBiologicalProcess	skeletal muscle fiber differentiation	HDAC9 HDAC5 RBM24	6.80e-04	16	229	3	GO:0098528
GeneOntologyBiologicalProcess	development of primary male sexual characteristics	ARID4B ADAM18 ESR1 SRD5A2 SFRP1 ADAM5 ADAM2 CSMD1	6.92e-04	172	229	8	GO:0046546
GeneOntologyBiologicalProcess	anterograde trans-synaptic signaling	RELN CACNA2D2 DGKB LILRB1 PLPPR4 NRXN1 NRXN2 ARHGAP44 IQSEC1 PLCG1 FCHSD1 LILRA1 LAMA2 CRTC1 GRM6 GRM7 IGF1R SLITRK5 MAPK1 MAPK3 FYN SEZ6	7.23e-04	931	229	22	GO:0098916
GeneOntologyBiologicalProcess	chemical synaptic transmission	RELN CACNA2D2 DGKB LILRB1 PLPPR4 NRXN1 NRXN2 ARHGAP44 IQSEC1 PLCG1 FCHSD1 LILRA1 LAMA2 CRTC1 GRM6 GRM7 IGF1R SLITRK5 MAPK1 MAPK3 FYN SEZ6	7.23e-04	931	229	22	GO:0007268
GeneOntologyBiologicalProcess	condensed mesenchymal cell proliferation	FAT4 DCHS1	7.26e-04	4	229	2	GO:0072137
GeneOntologyBiologicalProcess	neuroligin clustering involved in postsynaptic membrane assembly	NRXN1 NRXN2	7.26e-04	4	229	2	GO:0097118
GeneOntologyBiologicalProcess	regulation of Golgi inheritance	MAPK1 MAPK3	7.26e-04	4	229	2	GO:0090170
GeneOntologyBiologicalProcess	trans-synaptic signaling	RELN CACNA2D2 DGKB LILRB1 PLPPR4 NRXN1 NRXN2 ARHGAP44 IQSEC1 PLCG1 FCHSD1 LILRA1 LAMA2 CRTC1 GRM6 GRM7 IGF1R SLITRK5 MAPK1 MAPK3 FYN SEZ6	8.09e-04	939	229	22	GO:0099537
GeneOntologyBiologicalProcess	positive regulation of cell junction assembly	NRXN1 IQSEC1 ADGRL3 TBX5 SFRP1 ACTR3 SLITRK5	8.24e-04	136	229	7	GO:1901890
GeneOntologyBiologicalProcess	heart development	HDAC9 MYH10 ZMPSTE24 SRI ITGA4 GREB1L FES PLEC TBX5 HSPG2 FAT4 HDAC5 ABI3BP IGF1R GYS1 DCHS1 MAPK1 MAPK3 RBM24	8.27e-04	757	229	19	GO:0007507
GeneOntologyCellularComponent	collagen-containing extracellular matrix	RELN LAMA1 OTOL1 F3 SEMA6D MAMDC2 NID1 USH2A HSPG2 NID2 SFRP1 COL12A1 VWF ABI3BP ADAMTS4 TNC EFEMP2 LAMA2 LAMA4 ADAMTS8 MMRN1 P3H2	1.46e-07	530	234	22	GO:0062023
GeneOntologyCellularComponent	protein complex involved in cell-matrix adhesion	LAMA1 NID1 TNC LAMA2 MMRN1	9.34e-07	17	234	5	GO:0098637
GeneOntologyCellularComponent	basement membrane	LAMA1 NID1 USH2A HSPG2 NID2 TNC EFEMP2 LAMA2 LAMA4 P3H2	1.18e-06	122	234	10	GO:0005604
GeneOntologyCellularComponent	extracellular matrix	RELN LAMA1 OTOL1 F3 SEMA6D MAMDC2 NID1 USH2A HSPG2 NID2 SFRP1 COL12A1 VWF ABI3BP ADAMTS4 TNC EFEMP2 LAMA2 LAMA4 ADAMTS8 TECTA MMRN1 P3H2	1.43e-06	656	234	23	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	RELN LAMA1 OTOL1 F3 SEMA6D MAMDC2 NID1 USH2A HSPG2 NID2 SFRP1 COL12A1 VWF ABI3BP ADAMTS4 TNC EFEMP2 LAMA2 LAMA4 ADAMTS8 TECTA MMRN1 P3H2	1.51e-06	658	234	23	GO:0030312
GeneOntologyCellularComponent	protein complex involved in cell adhesion	LAMA1 ITGA4 NRXN1 NID1 TNC LAMA2 MMRN1	4.19e-06	59	234	7	GO:0098636
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO2 NOMO1 NOMO3	1.11e-04	9	234	3	GO:0160064
GeneOntologyCellularComponent	glutamatergic synapse	MYH10 DGKB CSMD2 DCX PLPPR4 NRXN1 NRXN2 ARHGAP44 IQSEC1 PLCG1 ADGRL3 CACNA2D1 CRTC1 NBEA GRM7 ACTR3 PTPRT IGF1R ELAVL2 MAPK3 FYN CDH10	1.37e-04	817	234	22	GO:0098978
GeneOntologyCellularComponent	side of membrane	MYH10 ENPP3 ITGA4 F3 LILRB1 B4GALT1 EPM2AIP1 PTPN4 PLPPR4 NEGR1 CNTN5 FES OTULINL LILRA1 IL31RA VWF MUC16 BIRC2 TECTA CTSA CD36 CD69 SLAMF7	1.37e-04	875	234	23	GO:0098552
GeneOntologyCellularComponent	inner dynein arm	DNAH6 DNAH2 DNAH1	1.57e-04	10	234	3	GO:0036156
GeneOntologyCellularComponent	hemidesmosome	EPPK1 PLEC ACTR3	2.14e-04	11	234	3	GO:0030056
GeneOntologyCellularComponent	presynaptic active zone membrane	CACNA2D2 NRXN1 NRXN2 CACNA2D1 GRM7 CDH10	2.42e-04	78	234	6	GO:0048787
GeneOntologyCellularComponent	catenin complex	CDH20 DCHS1 CDH10 CDH12	4.30e-04	32	234	4	GO:0016342
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO2 NOMO1 NOMO3	4.60e-04	14	234	3	GO:0072379
GeneOntologyCellularComponent	plasma membrane protein complex	CATSPERD CACNA2D2 ITGA4 LILRB1 CDH20 KCNF1 SCN9A HSPG2 CACNA2D1 LILRA1 BIRC2 IFNLR1 TRBV24-1 IGF1R TRBV7-7 TRBV7-6 DCHS1 ATP4A CDH10 CDH12	5.59e-04	785	234	20	GO:0098797
GeneOntologyCellularComponent	interstitial matrix	MAMDC2 ABI3BP TNC	8.39e-04	17	234	3	GO:0005614
GeneOntologyCellularComponent	synaptic membrane	CACNA2D2 DGKB CSMD2 PLPPR4 NRXN1 NRXN2 CNTN5 ADGRL3 CACNA2D1 IL31RA NBEA GRM6 GRM7 PTPRT SLITRK5 CDH10	9.26e-04	583	234	16	GO:0097060
GeneOntologyCellularComponent	cluster of actin-based cell projections	MYH10 MYO7B B4GALT1 PTPRQ PLEC USH2A SI ACTR3 CD36	9.54e-04	223	234	9	GO:0098862
GeneOntologyCellularComponent	presynaptic active zone	CACNA2D2 NRXN1 NRXN2 ARHGAP44 CACNA2D1 GRM7 CDH10	1.07e-03	141	234	7	GO:0048786
GeneOntologyCellularComponent	axon	RELN MYH10 ESR1 SRI ITGA4 DCX TUBB4A NEK3 NRXN1 CNTN5 SCN9A ACTL9 PLEC USH2A ADGRL3 IL31RA HDAC5 GRM7 IGF1R WDFY3 MAPK1	1.10e-03	891	234	21	GO:0030424
GeneOntologyCellularComponent	postsynapse	MYH10 SRI DGKB CSMD2 PLPPR4 ARHGAP44 IQSEC1 ADGRL3 CACNA2D1 ABI3BP LAMA2 CRTC1 NBEA GRM6 GRM7 ACTR3 PTPRT IGF1R SLITRK5 MAPK1 FYN CDH10 SEZ6	1.12e-03	1018	234	23	GO:0098794
GeneOntologyCellularComponent	sarcolemma	ESR1 SRI PLEC CACNA2D1 LAMA2 SLC2A5 IGF1R CD36	1.39e-03	190	234	8	GO:0042383
GeneOntologyCellularComponent	cell surface	EPHB6 ENPP3 ITGA4 F3 LILRB1 B4GALT1 SEMA6D PLPPR4 NRXN1 HSPD1 NID2 LILRA1 IL31RA SFRP1 VWF MUC16 PKD2L1 GRM7 PTPRT ARSB CD36 CD69 ADAM2 SLAMF7	1.61e-03	1111	234	24	GO:0009986
GeneOntologyCellularComponent	brush border	MYH10 MYO7B B4GALT1 PLEC SI ACTR3 CD36	1.65e-03	152	234	7	GO:0005903
GeneOntologyCellularComponent	sarcoplasm	MYH10 SRI AGL PLEC CACNA2D1 P3H2	1.80e-03	114	234	6	GO:0016528
GeneOntologyCellularComponent	Schaffer collateral - CA1 synapse	DGKB PLPPR4 NRXN1 IQSEC1 PLCG1 ADGRL3 FYN	1.85e-03	155	234	7	GO:0098685
GeneOntologyCellularComponent	primary lysosome	B4GALT1 GGH PIGR CTSA FRK ARSB MAPK1	2.21e-03	160	234	7	GO:0005766
GeneOntologyCellularComponent	azurophil granule	B4GALT1 GGH PIGR CTSA FRK ARSB MAPK1	2.21e-03	160	234	7	GO:0042582
GeneOntologyCellularComponent	receptor complex	ITGA4 PIGR PTPRQ HSPD1 IL31RA PKD2L1 BIRC2 GRM7 IFNLR1 TRBV24-1 IGF1R TRBV7-7 TRBV7-6 CD36 SLITRK5	2.40e-03	581	234	15	GO:0043235
GeneOntologyCellularComponent	neuron to neuron synapse	DGKB CSMD2 PLPPR4 NRXN1 ARHGAP44 IQSEC1 ABI3BP CRTC1 GRM7 PTPRT SLITRK5 ELAVL2 MAPK1 FYN	2.40e-03	523	234	14	GO:0098984
GeneOntologyCellularComponent	axonemal dynein complex	DNAH6 DNAH2 DNAH1	2.66e-03	25	234	3	GO:0005858
GeneOntologyCellularComponent	somatodendritic compartment	EPHB6 RELN MYH10 ESR1 SRD5A2 SRI ITGA4 DCX TUBB4A NRXN1 NEGR1 ARHGAP44 PLEC USH2A FCHSD1 ABI3BP LAMA2 CRTC1 GRM6 GRM7 IGF1R WDFY3 MAPK1 FYN SEZ6	2.85e-03	1228	234	25	GO:0036477
GeneOntologyCellularComponent	asymmetric synapse	DGKB CSMD2 PLPPR4 ARHGAP44 IQSEC1 ABI3BP CRTC1 GRM7 PTPRT SLITRK5 ELAVL2 MAPK1 FYN	2.92e-03	477	234	13	GO:0032279
GeneOntologyCellularComponent	anchoring junction	EPPK1 LAMA1 ITGA4 B4GALT1 PTPN12 CDH20 NRXN1 FES PLCG1 PLEC DNMBP ADGRL3 HSPG2 DSC2 TNC ACTR3 MAPK1 MAPK3 CDH10 CDH12 ATP6V0A2	3.28e-03	976	234	21	GO:0070161
GeneOntologyCellularComponent	azurophil granule lumen	GGH CTSA FRK ARSB MAPK1	3.59e-03	91	234	5	GO:0035578
Domain	LAM_G_DOMAIN	LAMA1 NRXN1 NRXN2 USH2A HSPG2 FAT4 LAMA2 LAMA4	1.40e-08	38	225	8	PS50025
Domain	-	LAMA1 NRXN1 NRXN2 USH2A HSPG2 FAT4 COL12A1 LAMA2 LAMA4 NBEA WDFY3	1.95e-08	95	225	11	2.60.120.200
Domain	Laminin_G_2	LAMA1 NRXN1 NRXN2 USH2A HSPG2 FAT4 LAMA2 LAMA4	2.16e-08	40	225	8	PF02210
Domain	Laminin_G	LAMA1 NRXN1 NRXN2 USH2A HSPG2 FAT4 COL12A1 LAMA2 LAMA4	2.91e-08	58	225	9	IPR001791
Domain	LamG	LAMA1 NRXN1 NRXN2 USH2A HSPG2 FAT4 LAMA2 LAMA4	4.78e-08	44	225	8	SM00282
Domain	EGF-like_dom	RELN ADAM18 LAMA1 NRXN1 NRXN2 NID1 HSPG2 NID2 FAT4 TNC EFEMP2 LAMA2 LAMA4 TECTA MMRN1	3.71e-07	249	225	15	IPR000742
Domain	ConA-like_dom	LAMA1 NRXN1 NRXN2 MAMDC2 USH2A HSPG2 FAT4 COL12A1 LAMA2 LAMA4 NBEA PTPRT MMRN1 WDFY3	4.49e-07	219	225	14	IPR013320
Domain	EGF_1	RELN ADAM18 LAMA1 NRXN1 NRXN2 NID1 USH2A HSPG2 FAT4 TNC EFEMP2 LAMA2 LAMA4 MMRN1 ADAM2	5.03e-07	255	225	15	PS00022
Domain	EGF	RELN LAMA1 NRXN1 NRXN2 NID1 HSPG2 NID2 FAT4 TNC EFEMP2 LAMA2 LAMA4 TECTA MMRN1	1.05e-06	235	225	14	SM00181
Domain	-	EPHB6 POGLUT3 F3 LILRB1 IGSF10 PIGR NOMO2 NEGR1 CNTN5 USH2A HSPG2 LILRA1 LILRA3 IL31RA COL12A1 ABI3BP TNC PTPRT IFNLR1 NOMO1 IGF1R SLAMF7 NOMO3 MYBPC1	1.66e-06	663	225	24	2.60.40.10
Domain	EGF-like_CS	RELN ADAM18 LAMA1 NRXN1 NRXN2 NID1 HSPG2 NID2 FAT4 TNC EFEMP2 LAMA2 LAMA4 MMRN1	3.60e-06	261	225	14	IPR013032
Domain	EGF_2	RELN ADAM18 LAMA1 NRXN1 NRXN2 NID1 HSPG2 NID2 FAT4 TNC EFEMP2 LAMA2 MMRN1 ADAM2	4.29e-06	265	225	14	PS01186
Domain	Ig-like_fold	EPHB6 POGLUT3 F3 LILRB1 IGSF10 PIGR NOMO2 NEGR1 CNTN5 USH2A HSPG2 LILRA1 LILRA3 IL31RA COL12A1 ABI3BP TNC PTPRT IFNLR1 NOMO1 IGF1R SLAMF7 NOMO3 MYBPC1	4.89e-06	706	225	24	IPR013783
Domain	DUF2012	NOMO2 NOMO1 NOMO3	6.84e-06	4	225	3	PF09430
Domain	DUF2012	NOMO2 NOMO1 NOMO3	6.84e-06	4	225	3	IPR019008
Domain	FN3_dom	EPHB6 F3 CNTN5 USH2A IL31RA COL12A1 ABI3BP TNC PTPRT IFNLR1 IGF1R MYBPC1	9.12e-06	209	225	12	IPR003961
Domain	NIDO_dom	NID1 NID2 TECTA	1.69e-05	5	225	3	IPR003886
Domain	NIDO	NID1 NID2 TECTA	1.69e-05	5	225	3	SM00539
Domain	NIDO	NID1 NID2 TECTA	1.69e-05	5	225	3	PF06119
Domain	Laminin_domII	LAMA1 LAMA2 LAMA4	1.69e-05	5	225	3	IPR010307
Domain	NIDO	NID1 NID2 TECTA	1.69e-05	5	225	3	PS51220
Domain	Laminin_aI	LAMA1 LAMA2 LAMA4	1.69e-05	5	225	3	IPR009254
Domain	Laminin_I	LAMA1 LAMA2 LAMA4	1.69e-05	5	225	3	PF06008
Domain	Laminin_II	LAMA1 LAMA2 LAMA4	1.69e-05	5	225	3	PF06009
Domain	EGF_LAM_2	LAMA1 USH2A HSPG2 LAMA2 LAMA4	2.71e-05	30	225	5	PS50027
Domain	EGF_LAM_1	LAMA1 USH2A HSPG2 LAMA2 LAMA4	2.71e-05	30	225	5	PS01248
Domain	fn3	EPHB6 CNTN5 USH2A IL31RA COL12A1 ABI3BP TNC PTPRT IGF1R MYBPC1	2.76e-05	162	225	10	PF00041
Domain	EGF_3	RELN ADAM18 NRXN1 NRXN2 NID1 HSPG2 NID2 FAT4 TNC EFEMP2 MMRN1 ADAM2	2.94e-05	235	225	12	PS50026
Domain	FN3	EPHB6 CNTN5 USH2A IL31RA COL12A1 ABI3BP TNC PTPRT IFNLR1 IGF1R MYBPC1	3.07e-05	199	225	11	PS50853
Domain	EGF_Lam	LAMA1 USH2A HSPG2 LAMA2 LAMA4	5.87e-05	35	225	5	SM00180
Domain	Laminin_EGF	LAMA1 USH2A HSPG2 LAMA2 LAMA4	5.87e-05	35	225	5	PF00053
Domain	FN3	EPHB6 CNTN5 USH2A IL31RA COL12A1 ABI3BP TNC PTPRT IGF1R MYBPC1	8.50e-05	185	225	10	SM00060
Domain	Laminin_EGF	LAMA1 USH2A HSPG2 LAMA2 LAMA4	8.81e-05	38	225	5	IPR002049
Domain	Carb-bd-like_fold	NOMO2 NOMO1 NOMO3	9.24e-05	8	225	3	IPR013784
Domain	LAMININ_IVA	LAMA1 HSPG2 LAMA2	9.24e-05	8	225	3	PS51115
Domain	Laminin_B	LAMA1 HSPG2 LAMA2	9.24e-05	8	225	3	PF00052
Domain	LamB	LAMA1 HSPG2 LAMA2	9.24e-05	8	225	3	SM00281
Domain	Laminin_IV	LAMA1 HSPG2 LAMA2	9.24e-05	8	225	3	IPR000034
Domain	Growth_fac_rcpt_	EPHB6 LAMA1 NID1 HSPG2 NID2 FAT4 TNC EFEMP2 IGF1R	1.17e-04	156	225	9	IPR009030
Domain	ELFV_dehydrog_N	GLUD1 GLUD2	1.44e-04	2	225	2	PF02812
Domain	Glu/Leu/Phe/Val_DH_C	GLUD1 GLUD2	1.44e-04	2	225	2	IPR006096
Domain	Glu/Leu/Phe/Val_DH_dimer_dom	GLUD1 GLUD2	1.44e-04	2	225	2	IPR006097
Domain	Glu/Leu/Phe/Val_DH	GLUD1 GLUD2	1.44e-04	2	225	2	IPR006095
Domain	ELFV_dehydrog	GLUD1 GLUD2	1.44e-04	2	225	2	PF00208
Domain	NAD_bind_Glu_DH	GLUD1 GLUD2	1.44e-04	2	225	2	IPR033922
Domain	GLFV_DEHYDROGENASE	GLUD1 GLUD2	1.44e-04	2	225	2	PS00074
Domain	MAPK_ERK1/2	MAPK1 MAPK3	1.44e-04	2	225	2	IPR008349
Domain	ELFV_dehydrog	GLUD1 GLUD2	1.44e-04	2	225	2	SM00839
Domain	Glu/Leu/Phe/Val_DH_AS	GLUD1 GLUD2	1.44e-04	2	225	2	IPR033524
Domain	EGF	NRXN1 NRXN2 NID1 HSPG2 NID2 TNC TECTA MMRN1	1.45e-04	126	225	8	PF00008
Domain	Cadherin_C	CDH20 DSC2 CDH10 CDH12	2.13e-04	25	225	4	PF01049
Domain	Cadherin_cytoplasmic-dom	CDH20 DSC2 CDH10 CDH12	2.13e-04	25	225	4	IPR000233
Domain	Laminin_G_1	LAMA1 HSPG2 LAMA2	2.65e-04	11	225	3	PF00054
Domain	ADAM_Cys-rich	ADAM18 ADAMTS4 ADAMTS8 ADAM2	2.89e-04	27	225	4	IPR006586
Domain	ACR	ADAM18 ADAMTS4 ADAMTS8 ADAM2	2.89e-04	27	225	4	SM00608
Domain	Cadherin_CS	CDH20 FAT4 DSC2 PCDHGA10 DCHS1 CDH10 CDH12	3.53e-04	109	225	7	IPR020894
Domain	Catenin_binding_dom	CDH20 DSC2 CDH10 CDH12	3.84e-04	29	225	4	IPR027397
Domain	-	CDH20 DSC2 CDH10 CDH12	3.84e-04	29	225	4	4.10.900.10
Domain	Cul7	CUL9 CUL7	4.30e-04	3	225	2	PF11515
Domain	Arp3_met	ACTR3B ACTR3	4.30e-04	3	225	2	IPR015623
Domain	HDAC4_Gln	HDAC9 HDAC5	4.30e-04	3	225	2	PF12203
Domain	CPH_domain	CUL9 CUL7	4.30e-04	3	225	2	IPR021097
Domain	G2F	NID1 NID2	4.30e-04	3	225	2	SM00682
Domain	Hist_deacetylase_Gln_rich_N	HDAC9 HDAC5	4.30e-04	3	225	2	IPR024643
Domain	CADHERIN_1	CDH20 FAT4 DSC2 PCDHGA10 DCHS1 CDH10 CDH12	4.39e-04	113	225	7	PS00232
Domain	Cadherin	CDH20 FAT4 DSC2 PCDHGA10 DCHS1 CDH10 CDH12	4.39e-04	113	225	7	PF00028
Domain	CarboxyPept_regulatory_dom	NOMO2 NOMO1 NOMO3	4.51e-04	13	225	3	IPR014766
Domain	-	NOMO2 NOMO1 NOMO3	4.51e-04	13	225	3	2.60.40.1120
Domain	CADHERIN_2	CDH20 FAT4 DSC2 PCDHGA10 DCHS1 CDH10 CDH12	4.64e-04	114	225	7	PS50268
Domain	-	CDH20 FAT4 DSC2 PCDHGA10 DCHS1 CDH10 CDH12	4.64e-04	114	225	7	2.60.40.60
Domain	CA	CDH20 FAT4 DSC2 PCDHGA10 DCHS1 CDH10 CDH12	4.89e-04	115	225	7	SM00112
Domain	Alkaline_phosphatase_core	ARSK ENPP3 ENPP7 ARSB	5.00e-04	31	225	4	IPR017850
Domain	Alkaline_Pase-like_a/b/a	ARSK ENPP3 ENPP7 ARSB	5.00e-04	31	225	4	IPR017849
Domain	-	ARSK ENPP3 ENPP7 ARSB	5.00e-04	31	225	4	3.40.720.10
Domain	Cadherin-like	CDH20 FAT4 DSC2 PCDHGA10 DCHS1 CDH10 CDH12	5.15e-04	116	225	7	IPR015919
Domain	Dynein_heavy_chain_D4_dom	DNAH6 DNAH2 DNAH1	5.69e-04	14	225	3	IPR024317
Domain	Dynein_HC_stalk	DNAH6 DNAH2 DNAH1	5.69e-04	14	225	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH6 DNAH2 DNAH1	5.69e-04	14	225	3	IPR013602
Domain	DHC_N2	DNAH6 DNAH2 DNAH1	5.69e-04	14	225	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH6 DNAH2 DNAH1	5.69e-04	14	225	3	IPR011704
Domain	MT	DNAH6 DNAH2 DNAH1	5.69e-04	14	225	3	PF12777
Domain	AAA_8	DNAH6 DNAH2 DNAH1	5.69e-04	14	225	3	PF12780
Domain	AAA_5	DNAH6 DNAH2 DNAH1	5.69e-04	14	225	3	PF07728
Domain	Cadherin	CDH20 FAT4 DSC2 PCDHGA10 DCHS1 CDH10 CDH12	5.70e-04	118	225	7	IPR002126
Domain	DHC_fam	DNAH6 DNAH2 DNAH1	7.05e-04	15	225	3	IPR026983
Domain	Dynein_heavy	DNAH6 DNAH2 DNAH1	7.05e-04	15	225	3	PF03028
Domain	Dynein_heavy_dom	DNAH6 DNAH2 DNAH1	7.05e-04	15	225	3	IPR004273
Domain	VDCC_a2/dsu	CACNA2D2 CACNA2D1	8.53e-04	4	225	2	IPR013680
Domain	G2F	NID1 NID2	8.53e-04	4	225	2	PF07474
Domain	EYA_dom	EYA4 EYA2	8.53e-04	4	225	2	IPR006545
Domain	NIDOGEN_G2	NID1 NID2	8.53e-04	4	225	2	PS50993
Domain	VGCC_alpha2	CACNA2D2 CACNA2D1	8.53e-04	4	225	2	PF08473
Domain	GFP	NID1 NID2	8.53e-04	4	225	2	IPR009017
Domain	EYA_fam	EYA4 EYA2	8.53e-04	4	225	2	IPR028472
Domain	Histone_deAcase_II_euk	HDAC9 HDAC5	8.53e-04	4	225	2	IPR017320
Domain	G2_nidogen/fibulin_G2F	NID1 NID2	8.53e-04	4	225	2	IPR006605
Domain	Laminin_N	LAMA1 USH2A LAMA2	8.60e-04	16	225	3	IPR008211
Domain	LamNT	LAMA1 USH2A LAMA2	8.60e-04	16	225	3	SM00136
Domain	LAMININ_NTER	LAMA1 USH2A LAMA2	8.60e-04	16	225	3	PS51117
Domain	Laminin_N	LAMA1 USH2A LAMA2	8.60e-04	16	225	3	PF00055
Pathway	KEGG_ECM_RECEPTOR_INTERACTION	RELN LAMA1 ITGA4 HSPG2 VWF TNC LAMA2 LAMA4 CD36	1.19e-06	84	180	9	M7098
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	LAMA1 ITGA4 NRXN1 NID1 PLEC HSPG2 NID2 COL12A1 VWF ADAMTS4 TNC EFEMP2 LAMA2 LAMA4 ADAMTS8 P3H2	1.50e-06	300	180	16	M610
Pathway	WP_FOCAL_ADHESION	RELN LAMA1 ITGA4 VWF TNC LAMA2 LAMA4 BIRC2 BIRC3 IGF1R MAPK1 MAPK3 FYN	1.63e-06	199	180	13	M39402
Pathway	KEGG_FOCAL_ADHESION	RELN LAMA1 ITGA4 VWF TNC LAMA2 LAMA4 BIRC2 BIRC3 IGF1R MAPK1 MAPK3 FYN	1.63e-06	199	180	13	M7253
Pathway	REACTOME_LAMININ_INTERACTIONS	LAMA1 NID1 HSPG2 NID2 LAMA2 LAMA4	1.84e-06	30	180	6	M27216
Pathway	BIOCARTA_LIS1_PATHWAY	RELN DCX DNAH6 DNAH2 DNAH1	3.23e-06	19	180	5	M22005
Pathway	BIOCARTA_PELP1_PATHWAY	ESR1 MAPK1 MAPK3	2.01e-05	5	180	3	MM1575
Pathway	WP_FOCAL_ADHESION	RELN LAMA1 ITGA4 VWF TNC LAMA2 LAMA4 BIRC2 BIRC3 MAPK1 FYN	2.81e-05	187	180	11	MM15913
Pathway	BIOCARTA_PELP1_PATHWAY	ESR1 MAPK1 MAPK3	3.98e-05	6	180	3	M22062
Pathway	BIOCARTA_AGR_PATHWAY	LAMA1 LAMA2 LAMA4 MAPK1 MAPK3	4.17e-05	31	180	5	MM1343
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	LAMA1 NRXN1 HSPG2 TNC LAMA2 LAMA4	1.02e-04	59	180	6	M27218
Pathway	PID_INTEGRIN1_PATHWAY	LAMA1 ITGA4 NID1 TNC LAMA2 LAMA4	1.92e-04	66	180	6	M18
Pubmed	Basement membrane composition in the early mouse embryo day 7.	LAMA1 NID1 HSPG2 NID2 LAMA2 LAMA4	4.14e-10	15	234	6	15895400
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	HGD MYH10 SRI PACSIN3 B4GALT1 GGH TUBB4A PIGR NID1 HSPG2 NID2 CACNA2D1 FAT4 DSC2 B4GAT1 SLC26A2 EFEMP2 GPX3 SI TMC4 GLOD4 ACTR3B CTSA ACTR3 SLC2A5 FRK ARSB PABPC1L	1.03e-09	1070	234	28	23533145
Pubmed	Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.	LAMA1 ITGA4 TNC LAMA2 LAMA4	1.63e-09	9	234	5	9882526
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	LAMA1 B4GALT1 GGH NID1 HSPG2 NID2 SFRP1 COL12A1 VWF TNC EFEMP2 GPX3 LAMA2 LAMA4	1.73e-09	248	234	14	24006456
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	RELN LAMA1 SEMA6D NID1 HSPG2 NID2 COL12A1 VWF TNC LAMA2 LAMA4 MMRN1	2.89e-09	175	234	12	28071719
Pubmed	Molecular dissection of laminin alpha 5 in vivo reveals separable domain-specific roles in embryonic development and kidney function.	LAMA1 NID1 HSPG2 LAMA2 LAMA4	1.01e-08	12	234	5	16750824
Pubmed	Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury.	LAMA1 NID1 HSPG2 NID2 TNC LAMA2 LAMA4 ADAMTS8	1.19e-08	64	234	8	22261194
Pubmed	LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow.	PECR MYH10 MCM4 GGH NOMO2 GLUD1 GLUD2 PLCG1 PLEC HSPD1 ACTR3 NOMO1 ARSB MAPK1 NOMO3	1.48e-08	344	234	15	30333137
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	LAMA1 NID1 HSPG2 COL12A1 VWF ABI3BP TNC EFEMP2 LAMA2 LAMA4 MMRN1	2.03e-08	167	234	11	22159717
Pubmed	Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics.	NID1 HSPG2 NID2 COL12A1 VWF ABI3BP TNC LAMA2 LAMA4 MMRN1	2.96e-08	135	234	10	28675934
Pubmed	Presynaptic α2δ-2 Calcium Channel Subunits Regulate Postsynaptic GABAA Receptor Abundance and Axonal Wiring.	CACNA2D2 NRXN1 NRXN2 CACNA2D1	2.96e-08	6	234	4	30683685
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	LAMA1 NID1 HSPG2 NID2 COL12A1 ADAMTS4 TNC	4.46e-08	50	234	7	23658023
Pubmed	Patterns of laminins and integrins in the embryonic ventricular zone of the CNS.	LAMA1 NID1 HSPG2 LAMA2 LAMA4	5.43e-08	16	234	5	17948866
Pubmed	Transcriptome-based systematic identification of extracellular matrix proteins.	LAMA1 MAMDC2 NID1 HSPG2 NID2 ABI3BP LAMA2 LAMA4	6.44e-08	79	234	8	18757743
Pubmed	Specific ablation of the nidogen-binding site in the laminin gamma1 chain interferes with kidney and lung development.	LAMA1 NID1 HSPG2 NID2	1.37e-07	8	234	4	12015298
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	EPHB6 FBXW10B ADAM18 DGKB ENPP7 FBXW10 ADAMTS4 TPTE2 DNAH2 BIRC2 ADAMTS8 FRK IGF1R EIF4A1 ADAM2 MAPK1 MAPK3 FYN ATP4A ATP6V0A2	1.39e-07	730	234	20	34857952
Pubmed	Bag1 is essential for differentiation and survival of hematopoietic and neuronal cells.	DCX BIRC2 BIRC3 MAPK1 MAPK3	1.42e-07	19	234	5	16116448
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	ZMPSTE24 ARSK TM9SF3 LAMA1 PTDSS1 B4GALT1 GGH IGSF10 PTPN12 NOMO2 NEGR1 NID1 HSPG2 CACNA2D1 FAM234B FAT4 COL12A1 B4GAT1 LAMA4 CTSA DEGS1 NOMO1 IGF1R P3H2 SLITRK5 ATP6V0A2	1.84e-07	1201	234	26	35696571
Pubmed	Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.	HSPD1 MAPK1 MAPK3	3.01e-07	3	234	3	29415987
Pubmed	Expression of novel neurotrophin-1/B-cell stimulating factor-3 (NNT-1/BSF-3) in murine pituitary folliculostellate TtT/GF cells: pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide-induced stimulation of NNT-1/BSF-3 is mediated by protein kinase A, protein kinase C, and extracellular-signal-regulated kinase1/2 pathways.	MAPK1 MAPK3 CLCF1	3.01e-07	3	234	3	14605001
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO2 NOMO1 NOMO3	3.01e-07	3	234	3	36011023
Pubmed	ERα and ERK1/2 MAP kinase expression in microdissected stromal and epithelial endometrial cells.	ESR1 MAPK1 MAPK3	3.01e-07	3	234	3	24565681
Pubmed	Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1/2 and p38 MAPK.	BIRC3 MAPK1 MAPK3	3.01e-07	3	234	3	15078890
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO2 NOMO1 NOMO3	3.01e-07	3	234	3	25576386
Pubmed	Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.	NID1 HSPG2 NID2 SFRP1 ABI3BP TNC LAMA2 LAMA4	3.22e-07	97	234	8	27559042
Pubmed	Primary cellular meningeal defects cause neocortical dysplasia and dyslamination.	LAMA1 NID1 LAMA2 LAMA4	4.06e-07	10	234	4	20976766
Pubmed	Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis.	LAMA1 HSPG2 TNC LAMA2 LAMA4	6.29e-07	25	234	5	19373938
Pubmed	Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities.	LAMA1 DCX LAMA2 LAMA4	6.35e-07	11	234	4	23472759
Pubmed	Laminin alpha 5 is required for lobar septation and visceral pleural basement membrane formation in the developing mouse lung.	LAMA1 NID1 LAMA2 LAMA4	6.35e-07	11	234	4	12051813
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	NID1 HSPG2 NID2 COL12A1 VWF ABI3BP TNC LAMA2 LAMA4	7.04e-07	146	234	9	27068509
Pubmed	Phrenic-specific transcriptional programs shape respiratory motor output.	CDH20 NEGR1 PTPRT CDH10 CDH12	9.45e-07	27	234	5	31944180
Pubmed	Retinoic acid deficiency alters second heart field formation.	HOXA1 TBX5 MAPK1 MAPK3	9.48e-07	12	234	4	18287057
Pubmed	RSK2 Maintains Adult Estrogen Homeostasis by Inhibiting ERK1/2-Mediated Degradation of Estrogen Receptor Alpha.	ESR1 MAPK1 MAPK3	1.20e-06	4	234	3	32697984
Pubmed	An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism.	GGPS1 MAPK1 MAPK3	1.20e-06	4	234	3	21321112
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO2 NOMO1 NOMO3	1.20e-06	4	234	3	31833031
Pubmed	Co-engagement of alpha(4)beta(1) integrin (VLA-4) and CD4 or CD8 is necessary to induce maximal Erk1/2 phosphorylation and cytokine production in human T cells.	ITGA4 MAPK1 MAPK3	1.20e-06	4	234	3	19815047
Pubmed	Gαo potentiates estrogen receptor α activity via the ERK signaling pathway.	ESR1 MAPK1 MAPK3	1.20e-06	4	234	3	22562654
Pubmed	LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.	LILRB1 LILRA1 LILRA3	1.20e-06	4	234	3	21559424
Pubmed	Signal pathway of 17beta-estradiol-induced MUC5B expression in human airway epithelial cells.	ESR1 MAPK1 MAPK3	1.20e-06	4	234	3	18688042
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO2 NOMO1 NOMO3	1.20e-06	4	234	3	9267806
Pubmed	Regulation of AMPK activation by CD36 links fatty acid uptake to β-oxidation.	STK11 CD36 FYN	1.20e-06	4	234	3	25157091
Pubmed	Induction of endothelial cell proliferation by recombinant and microparticle-tissue factor involves beta1-integrin and extracellular signal regulated kinase activation.	F3 MAPK1 MAPK3	1.20e-06	4	234	3	20616308
Pubmed	Laminin alpha 1, alpha 2, alpha 4 and beta 1 chain mRNA expression in mouse embryonic, neonatal, and adult hearts.	LAMA1 LAMA2 LAMA4	1.20e-06	4	234	3	9201115
Pubmed	Simultaneous measurement of ERα, HER2, and phosphoERK1/2 in breast cancer cell lines by flow cytometry.	ESR1 MAPK1 MAPK3	1.20e-06	4	234	3	21607585
Pubmed	ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes.	LAMA1 MAPK1 MAPK3	1.20e-06	4	234	3	21115804
Pubmed	Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells.	ESR1 MAPK1 MAPK3	1.20e-06	4	234	3	14985328
Pubmed	HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding.	LILRB1 LILRA1 LILRA3	1.20e-06	4	234	3	21270408
Pubmed	Basement membranes in skin are differently affected by lack of nidogen 1 and 2.	NID1 HSPG2 NID2 LAMA4	1.36e-06	13	234	4	18356808
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	HGD GALM ZMPSTE24 ENPP3 SRI PACSIN3 B4GALT1 GGH STK11 PIGR NID1 HSPD1 HSPG2 CACNA2D1 VWF DSC2 TECTA CTSA ACTR3 SLC2A5 FRK SLC6A13	1.70e-06	1016	234	22	19056867
Pubmed	Transcriptional map of chromosome region 6q16-->q21.	ESR1 LAMA2 LAMA4 FYN	1.90e-06	14	234	4	10575223
Pubmed	The laminin alpha chains: expression, developmental transitions, and chromosomal locations of alpha1-5, identification of heterotrimeric laminins 8-11, and cloning of a novel alpha3 isoform.	LAMA1 LAMA2 LAMA4 FYN	1.90e-06	14	234	4	9151674
Pubmed	Defective glomerulogenesis in the absence of laminin alpha5 demonstrates a developmental role for the kidney glomerular basement membrane.	LAMA1 NID1 LAMA2 LAMA4	2.57e-06	15	234	4	10625553
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	HGD EYA2 NRXN1 GLUD1 VWF ADAMTS8 GRM7 PTPRT IGF1R	2.62e-06	171	234	9	20201926
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MYH10 DCX EPM2AIP1 PTPN9 LDB1 PLPPR4 NRXN1 ARHGAP44 IQSEC1 CACNA2D1 RANBP2 USP28 NBEA WDR91 EIF4A1 DCHS1 ELAVL2 WDFY3 MAPK1 MAPK3 CDH10	2.66e-06	963	234	21	28671696
Pubmed	Polymeric immunoglobulin receptor-mediated invasion of Streptococcus pneumoniae into host cells requires a coordinate signaling of SRC family of protein-tyrosine kinases, ERK, and c-Jun N-terminal kinase.	PIGR MAPK1 MAPK3	2.98e-06	5	234	3	20829350
Pubmed	Abnormalities of insulin-like growth factor-I signaling and impaired cell proliferation in osteoblasts from subjects with osteoporosis.	IGF1R MAPK1 MAPK3	2.98e-06	5	234	3	18079194
Pubmed	Differential expression of laminin alpha chains during murine tooth development.	LAMA1 LAMA2 LAMA4	2.98e-06	5	234	3	9389447
Pubmed	Caveolin-1 interferes cell growth of lung cancer NCI-H446 cell through the interactions with phospho-ERK1/2, estrogen receptor and progestin receptor.	ESR1 MAPK1 MAPK3	2.98e-06	5	234	3	22564243
Pubmed	Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways.	F3 MAPK1 MAPK3	2.98e-06	5	234	3	20451919
Pubmed	Mapping of binding sites for nidogens, fibulin-2, fibronectin and heparin to different IG modules of perlecan.	NID1 HSPG2 NID2	2.98e-06	5	234	3	11493006
Pubmed	Myocyte enhancer factor 2 and class II histone deacetylases control a gender-specific pathway of cardioprotection mediated by the estrogen receptor.	HDAC9 ESR1 HDAC5	2.98e-06	5	234	3	19893013
Pubmed	The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells.	IGF1R MAPK1 MAPK3	2.98e-06	5	234	3	17620336
Pubmed	Cross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells.	IGF1R MAPK1 MAPK3	2.98e-06	5	234	3	20731749
Pubmed	CD36-mediated cholesterol efflux is associated with PPARgamma activation via a MAPK-dependent COX-2 pathway in macrophages.	CD36 MAPK1 MAPK3	2.98e-06	5	234	3	19377069
Pubmed	Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney.	LAMA1 LAMA2 LAMA4	2.98e-06	5	234	3	9415429
Pubmed	Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor α/β in low doses of bisphenol A promoting growth of Sertoli TM4 cells.	ESR1 MAPK1 MAPK3	2.98e-06	5	234	3	24495410
Pubmed	SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells.	GLUD1 GLUD2 HSPD1	2.98e-06	5	234	3	16959573
Pubmed	Ubiquitinated CD36 sustains insulin-stimulated Akt activation by stabilizing insulin receptor substrate 1 in myotubes.	CUL7 CD36 FYN	2.98e-06	5	234	3	29269414
Pubmed	Binding of mouse nidogen-2 to basement membrane components and cells and its expression in embryonic and adult tissues suggest complementary functions of the two nidogens.	NID1 HSPG2 NID2	2.98e-06	5	234	3	12243745
Pubmed	Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin alpha3B and alpha5 chains.	LAMA1 NID1 LAMA2	2.98e-06	5	234	3	11829758
Pubmed	Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections.	LAMA1 NID1 LAMA2	2.98e-06	5	234	3	8613743
Pubmed	Developmental basis of sexually dimorphic digit ratios.	ESR1 MAPK1 MAPK3	2.98e-06	5	234	3	21896736
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	EYA4 TM9SF3 RBM26 MCM4 OTOL1 EYA2 ANKHD1 PTPN4 PTPN9 PTPN12 AGL GLUD1 NID1 PLCG1 HSPD1 RANBP2 POLE2 TPTE2 NOMO1 MAPK1 MAPK3	3.17e-06	974	234	21	28675297
Pubmed	The fibronectin leucine-rich repeat transmembrane protein Flrt2 is required in the epicardium to promote heart morphogenesis.	ITGA4 HSPG2 MAPK1 MAPK3	3.41e-06	16	234	4	21350012
Pubmed	Identification of a novel cell-adhesive protein spatiotemporally expressed in the basement membrane of mouse developing hair follicle.	NID1 HSPG2 NID2 TNC	3.41e-06	16	234	4	15878328
Pubmed	Laminin α1 is essential for mouse cerebellar development.	LAMA1 NID1 LAMA2 LAMA4	4.44e-06	17	234	4	21983115
Pubmed	Integrin-linked kinase is an adaptor with essential functions during mouse development.	NID1 NID2 MAPK1 MAPK3	5.68e-06	18	234	4	19829382
Pubmed	Focal adhesion kinase is required for neural crest cell morphogenesis during mouse cardiovascular development.	DCX HSPG2 MAPK1 MAPK3	5.68e-06	18	234	4	19587446
Pubmed	Proteomics characterization of extracellular space components in the human aorta.	NID1 HSPG2 NID2 SFRP1 COL12A1 ABI3BP TNC	5.74e-06	101	234	7	20551380
Pubmed	Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization.	LAMA1 NID1 LAMA2	5.92e-06	6	234	3	1678389
Pubmed	HIV-protein-mediated alterations in T cell interactions with the extracellular matrix proteins and endothelium.	LAMA1 LAMA2 LAMA4	5.92e-06	6	234	3	9597096
Pubmed	Elevated insulin signaling disrupts the growth and differentiation pattern of the mouse lens.	IGF1R MAPK1 MAPK3	5.92e-06	6	234	3	17417601
Pubmed	The type XIII collagen ectodomain is a 150-nm rod and capable of binding to fibronectin, nidogen-2, perlecan, and heparin.	NID1 HSPG2 NID2	5.92e-06	6	234	3	11956183
Pubmed	Impaired primary mouse myotube formation on crosslinked type I collagen films is enhanced by laminin and entactin.	LAMA1 NID1 LAMA2	5.92e-06	6	234	3	26555376
Pubmed	Effect of basement membrane entactin on epidermal cell attachment and growth.	LAMA1 NID1 LAMA2	5.92e-06	6	234	3	3794389
Pubmed	Nidogen-2: a new basement membrane protein with diverse binding properties.	NID1 HSPG2 NID2	5.92e-06	6	234	3	9733643
Pubmed	ANG II-induced cell proliferation is dually mediated by c-Src/Yes/Fyn-regulated ERK1/2 activation in the cytoplasm and PKCzeta-controlled ERK1/2 activity within the nucleus.	MAPK1 MAPK3 FYN	5.92e-06	6	234	3	16723512
Pubmed	CCR7/CCL21 migration on fibronectin is mediated by phospholipase Cgamma1 and ERK1/2 in primary T lymphocytes.	PLCG1 MAPK1 MAPK3	5.92e-06	6	234	3	20889506
Pubmed	Involvement of ERK1/2/NF-κB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620.	F3 MAPK1 MAPK3	5.92e-06	6	234	3	21625939
Pubmed	Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins.	NID1 HSPG2 NID2	5.92e-06	6	234	3	10544250
Pubmed	Laminin-nidogen complex. Extraction with chelating agents and structural characterization.	LAMA1 NID1 LAMA2	5.92e-06	6	234	3	3109910
Pubmed	Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution.	LAMA1 NID1 LAMA2	5.92e-06	6	234	3	23948589
Pubmed	A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction.	NID2 LAMA2 LAMA4	5.92e-06	6	234	3	18817539
Pubmed	Entactin: structure and function.	LAMA1 NID1 LAMA2	5.92e-06	6	234	3	2119632
Pubmed	Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and Fyn.	NRXN1 PTPRT FYN	5.92e-06	6	234	3	19816407
Pubmed	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.	FAT4 DSC2 DCHS1 MAPK1 MAPK3 NOMO3	6.16e-06	67	234	6	21875946
Pubmed	Identification of new putative susceptibility genes for several psychiatric disorders by association analysis of regulatory and non-synonymous SNPs of 306 genes involved in neurotransmission and neurodevelopment.	RELN ESR1 HOXA1 NRXN1 NRXN2 CNTN5 PLCG1 NBEA GRM6 GRM7 SLC6A13	6.80e-06	300	234	11	19086053
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ARID4B TM9SF3 CSMD2 PTPN9 FECH TRAPPC11 FAT4 TNC DNAH2 MUC16 NBEA GYS1 SS18L1 ELAVL2 WDFY3 NOMO3	7.83e-06	638	234	16	31182584
Pubmed	Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules.	HDAC9 HDAC5 MAPK1 MAPK3	8.89e-06	20	234	4	21421818
Pubmed	Odd skipped-related 1 identifies a population of embryonic fibro-adipogenic progenitors regulating myogenesis during limb development.	TBX5 COL12A1 MAPK1 MAPK3	8.89e-06	20	234	4	29084951
Interaction	FBXO2 interactions	POGLUT3 CACNA2D2 ARSK LAMA1 ITGA4 CUL7 NID1 HSPG2 NID2 CACNA2D1 COL12A1 DSC2 LAMA4 NOMO1 IGF1R ARSB SLAMF7 NOMO3	1.19e-06	411	229	18	int:FBXO2
Interaction	LLCFC1 interactions	POGLUT3 CACNA2D2 ARSK ITGA4 NID2 CACNA2D1 FAT4 NOMO1 ARSB DCHS1	1.24e-06	121	229	10	int:LLCFC1
Interaction	LILRA3 interactions	LILRB1 LILRA1 LILRA3 DSC2	5.03e-06	11	229	4	int:LILRA3
Interaction	SUSD4 interactions	POGLUT3 ARSK NID2 CACNA2D1 FAM234B ARSB	2.11e-05	50	229	6	int:SUSD4
Interaction	CASP9 interactions	HSPD1 BIRC2 BIRC3 ACTR3 EIF4A1 MAPK1 MAPK3	2.73e-05	77	229	7	int:CASP9
GeneFamily	Fibronectin type III domain containing	EPHB6 CNTN5 PTPRQ USH2A IL31RA COL12A1 ABI3BP TNC PTPRT IGF1R MYBPC1	5.39e-07	160	178	11	555
GeneFamily	Laminin subunits	LAMA1 LAMA2 LAMA4	1.93e-04	12	178	3	626
GeneFamily	CD molecules\|Type II classical cadherins	CDH20 CDH10 CDH12	2.50e-04	13	178	3	1186
GeneFamily	Histone deacetylases, class IIA	HDAC9 HDAC5	5.71e-04	4	178	2	992
GeneFamily	EYA transcriptional coactivator and phosphatases	EYA4 EYA2	5.71e-04	4	178	2	1044
GeneFamily	Dyneins, axonemal	DNAH6 DNAH2 DNAH1	5.76e-04	17	178	3	536
GeneFamily	Protein tyrosine phosphatases, non-receptor type	PTPN4 PTPN9 PTPN12	6.87e-04	18	178	3	812
GeneFamily	CD molecules\|Activating leukocyte immunoglobulin like receptors	LILRA1 LILRA3	1.41e-03	6	178	2	1181
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	PACSIN3 FES FCHSD1	1.44e-03	23	178	3	1288
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	ENPP3 ITGA4 F3 LILRB1 LILRA1 LILRA3 IGF1R TNFSF8 CD36 CD69 SLAMF7	1.85e-03	394	178	11	471
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	ADAM18 ADAM5 ADAM2	2.31e-03	27	178	3	47
GeneFamily	Ring finger proteins\|Baculoviral IAP repeat containing\|Caspase recruitment domain containing	BIRC2 BIRC3	2.60e-03	8	178	2	419
GeneFamily	EF-hand domain containing\|Plakins	EPPK1 PLEC	2.60e-03	8	178	2	939
GeneFamily	Cullins	CUL9 CUL7	2.60e-03	8	178	2	1032
GeneFamily	Glutamate metabotropic receptors\|Protein phosphatase 1 regulatory subunits	GRM6 GRM7	2.60e-03	8	178	2	281
GeneFamily	Adenylate kinases	AK9 AK8	3.32e-03	9	178	2	356
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEA WDFY3	3.32e-03	9	178	2	1230
GeneFamily	WD repeat domain containing\|F-box and WD repeat domain containing	FBXW10B FBXW10	5.00e-03	11	178	2	559
Coexpression	NABA_ECM_GLYCOPROTEINS	RELN LAMA1 OTOL1 IGSF10 NID1 USH2A NID2 VWF ABI3BP TNC EFEMP2 LAMA2 LAMA4 TECTA MMRN1	2.64e-10	196	232	15	M3008
Coexpression	NABA_CORE_MATRISOME	RELN LAMA1 OTOL1 IGSF10 NID1 USH2A HSPG2 NID2 COL12A1 VWF ABI3BP TNC EFEMP2 LAMA2 LAMA4 TECTA MMRN1	4.63e-10	275	232	17	M5884
Coexpression	NABA_ECM_GLYCOPROTEINS	RELN LAMA1 OTOL1 IGSF10 NID1 NID2 VWF ABI3BP TNC EFEMP2 LAMA2 LAMA4 TECTA MMRN1	1.86e-09	191	232	14	MM17059
Coexpression	NABA_CORE_MATRISOME	RELN LAMA1 OTOL1 IGSF10 NID1 HSPG2 NID2 COL12A1 VWF ABI3BP TNC EFEMP2 LAMA2 LAMA4 TECTA MMRN1	2.81e-09	270	232	16	MM17057
Coexpression	NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR	LAMA1 NID1 HSPG2 NID2 COL12A1 TNC LAMA4	2.12e-08	35	232	7	MM17054
Coexpression	NABA_MATRISOME	RELN ADAM18 LAMA1 OTOL1 IGSF10 SEMA6D NID1 HSPG2 NID2 SFRP1 COL12A1 VWF ABI3BP ADAMTS4 TNC EFEMP2 LAMA2 LAMA4 MUC16 ADAMTS8 TECTA CTSA MMRN1 P3H2 TNFSF8 ADAM5 LTA ADAM2 CLCF1	2.59e-08	1008	232	29	MM17056
Coexpression	NABA_MATRISOME	RELN ADAM18 LAMA1 OTOL1 IGSF10 SEMA6D NID1 USH2A HSPG2 NID2 SFRP1 COL12A1 VWF ABI3BP ADAMTS4 TNC EFEMP2 LAMA2 LAMA4 MUC16 ADAMTS8 TECTA CTSA MMRN1 P3H2 TNFSF8 LTA ADAM2 CLCF1	3.79e-08	1026	232	29	M5889
Coexpression	NABA_BASEMENT_MEMBRANES	LAMA1 NID1 USH2A HSPG2 NID2 LAMA2 LAMA4	5.65e-08	40	232	7	M5887
Coexpression	SABATES_COLORECTAL_ADENOMA_DN	LAMA1 ITGA4 SEMA6D NRXN1 MAMDC2 SCN9A SFRP1 ABI3BP SLC26A2 GPX3 SI CD36 NR5A2 RBM24	5.08e-07	299	232	14	M14791
Coexpression	BENPORATH_ES_WITH_H3K27ME3	EYA4 ESR1 SRD5A2 ITGA4 CSMD2 DCX HOXA1 HOXB8 HOXC6 SEMA6D NRXN1 NEGR1 KCNF1 SOX14 PLEC ADGRL3 TBX5 SFRP1 COL12A1 GRM6 GRM7 PTPRT BARHL1 PRDM13 ELAVL2 CSMD1 SEZ6	2.31e-06	1115	232	27	M10371
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBGABA	EYA4 CSMD2 DCX SEMA6D PLPPR4 NRXN1 NRXN2 NEGR1 SCN9A SOX14 ANKRD12 B4GALNT4 NBEA GRM7 PTPRT CELF3 SS18L1 ELAVL2 CSMD1 SEZ6	5.06e-06	703	232	20	M39070
Coexpression	HEVNER_TELENCEPHALON_VASCULAR_ENDOTHELIUM_AND_MENINGEAL_CELLS	ITGA4 NID1 HSPG2 NID2	7.56e-06	15	232	4	MM402
Coexpression	ZHONG_PFC_C3_MICROGLIA	MYH10 CSMD2 DCX EPM2AIP1 TUBB4A NRXN1 NRXN2 B4GALNT4 B4GAT1 NBEA ACTR3B CELF3 RBM24 CSMD1 FYN CDH10	8.16e-06	488	232	16	M39104
Coexpression	GSE6875_TCONV_VS_FOXP3_KO_TREG_DN	PECR COQ2 NID1 PLCG1 DNMBP FBXW10 SLC35B3 NBEA SLC6A13 HLTF	1.26e-05	200	232	10	M6802
Coexpression	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP	ITGA4 GPR108 ABI3BP TNC SLC6A13 IGF1R LTA XKRX ANKRD33B	1.42e-05	161	232	9	M9446
Coexpression	YAMAZAKI_TCEB3_TARGETS_UP	LAMA1 F3 PTPN9 HOXC6 SEMA6D NID1 HSPG2 NID2 EFEMP2	1.81e-05	166	232	9	M1542
Coexpression	TRAVAGLINI_LUNG_VEIN_CELL	HDAC9 VWF ABI3BP ADAMTS4 MMRN1	2.66e-05	40	232	5	M41663
Coexpression	YAMAZAKI_TCEB3_TARGETS_UP	LAMA1 F3 PTPN9 HOXC6 SEMA6D NID1 HSPG2 NID2 EFEMP2	3.29e-05	179	232	9	MM660
Coexpression	MIKKELSEN_IPS_WITH_HCP_H3K27ME3	HOXB8 PRDM8 HOXC6 ADGRL3 TBX5 PRDM13 SLC25A31	3.75e-05	103	232	7	M1967
Coexpression	MIKKELSEN_IPS_WITH_HCP_H3K27ME3	HOXB8 PRDM8 HOXC6 ADGRL3 TBX5 PRDM13 SLC25A31	4.51e-05	106	232	7	MM1265
Coexpression	DOUGLAS_BMI1_TARGETS_UP	ZMYND19 POGLUT3 EYA2 TUBB4A PRDM8 ZFYVE9 RHOBTB2 IQSEC1 NID1 TBX5 MED13L SS18L1 RCL1 DCHS1 MAPK3 RBM24	4.63e-05	563	232	16	M15103
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	RELN RBM26 CSMD2 DCX PRDM8 SEMA6D PLPPR4 NRXN1 NRXN2 NEGR1 CNTN5 SCN9A SOX14 ANKRD12 ADGRL3 B4GALNT4 NBEA MED13L GRM7 PTPRT CELF3 SLITRK5 ELAVL2 CSMD1	5.11e-05	1106	232	24	M39071
Coexpression	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A	PI4K2B HGD CACNA2D2 VN1R17P GPR108 TUBB4A CDH20 PLEC DNMBP GGPS1 TNC MUC16 GLOD4 ADAMTS8 TECTA DEGS1 ARSB DCHS1 CD69 ANKRD33B SEZ6	5.48e-05	899	232	21	M2242
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA1	RELN CSMD2 DCX PRDM8 SEMA6D PLPPR4 NRXN1 NRXN2 NEGR1 SCN9A FAT4 NBEA CELF3 ELAVL2 ADAM2 CSMD1	7.12e-05	584	232	16	M39068
Coexpression	GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN	MYH10 ARSK EYA2 PTPN12 PLCG1 FCHSD1 SLC26A2 MMRN1 WDFY3	7.20e-05	198	232	9	M7480
Coexpression	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	NID2 ABI3BP LAMA4 BIRC3 FYN	7.22e-05	49	232	5	M2899
Coexpression	BENPORATH_EED_TARGETS	RELN EYA4 SRD5A2 EYA2 ITGA4 HOXA1 GREB1L HOXB8 HOXC6 SEMA6D SOX14 PLEC ADGRL3 TBX5 SFRP1 COL12A1 GRM7 PTPRT BARHL1 PRDM13 ELAVL2 RBM24 CSMD1	7.28e-05	1059	232	23	M7617
Coexpression	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	PECR EYA4 EPPK1 NOMO2 NEGR1 MAMDC2 NBEA NOMO1 TG IGF1R NOMO3	7.42e-05	297	232	11	MM1003
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL	EYA4 NRXN1 CACNA2D1 COL12A1 GPX3 MMRN1 CELF3 CDH10	7.52e-05	155	232	8	M45695
Coexpression	GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN	LDB1 OTULINL PLEC FCHSD1 FAM234B RANBP2 BAZ2B SLC35B3 SEZ6	7.78e-05	200	232	9	M9763
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	RELN CACNA2D2 VN1R17P EYA2 F3 IGSF10 PTPN12 PIGR NID1 NID2 CACNA2D1 SFRP1 VWF TNC LAMA2 NBEA ACTR3B FYN	8.28e-05	721	232	18	M1999
Coexpression	GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN	CATSPERD MCM4 HELB TTC5 FBXW10 NOMO1 WDR91 GYS1	1.16e-04	165	232	8	M353
Coexpression	NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS	LAMA1 NID1 NID2 TNC	1.19e-04	29	232	4	MM17055
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL	EYA4 DCX NRXN1 IQSEC1 CACNA2D1 COL12A1 GPX3 NBEA NLRP2 MMRN1 CELF3 DCHS1 CDH10	1.28e-04	429	232	13	M45694
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	HDAC9 RELN TM9SF3 ANKHD1 TUBB4A CDH20 SEMA6D NEGR1 ANKRD12 PLEC TTC5 ADGRL3 CACNA2D1 FAM234B HDAC5 ADAMTS4 BAZ2B SLC26A2 ARSB FYN CDH10 MAD2L1 ATP6V0A2	1.31e-04	1102	232	23	M2369
Coexpression	HEVNER_SUBPLATE_PROJECTION_NEURONS	NRXN1 CDH10 CDH12	1.42e-04	12	232	3	MM416
Coexpression	HEVNER_INTERMEDIATE_ZONE_AND_UP_POSTMITOTIC_PROJECTION_NEURONS	PTPN4 PRDM8 SEMA6D CACNA2D1 HDAC5	1.50e-04	57	232	5	MM415
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	HDAC9 RELN TM9SF3 ANKHD1 TUBB4A CDH20 SEMA6D NEGR1 ANKRD12 PLEC TTC5 ADGRL3 CACNA2D1 FAM234B HDAC5 ADAMTS4 BAZ2B SLC26A2 ARSB FYN CDH10 MAD2L1 ATP6V0A2	1.75e-04	1124	232	23	MM1070
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA	RELN DCX PRDM8 SEMA6D PLPPR4 NRXN1 NRXN2 NEGR1 SCN9A ANKRD12 MUC16 CELF3 ELAVL2 CSMD1	1.82e-04	506	232	14	M39067
Coexpression	BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A	PI4K2B HGD CACNA2D2 GPR108 TUBB4A CDH20 PLEC DNMBP GGPS1 TNC MUC16 GLOD4 ADAMTS8 TECTA DEGS1 ARSB DCHS1 CD69 ANKRD33B SEZ6	2.48e-04	930	232	20	MM893
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4	HDAC9 EYA4 GALM CUL7 DCX GREB1L GGH IGSF10 SEMA6D NRXN1 NEGR1 PTPRQ ANKRD12 OTULINL ADGRL3 CACNA2D1 FAT4 SFRP1 VWF B4GAT1 ABI3BP EFEMP2 DNAH2 LAMA2 LAMA4 NBEA MMRN1 ARSB DCHS1 CLCF1 MYBPC1	9.94e-07	1148	220	31	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	POGLUT3 LAMA1 ITGA4 B4GALT1 IGSF10 HOXC6 CACNA2D1 SFRP1 EFEMP2 GPX3 LAMA2 MUC16 FRK P3H2 DCHS1	2.47e-06	336	220	15	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2	EYA4 GALM CACNA2D2 CUL7 F3 B4GALT1 GREB1L IGSF10 NRXN1 NEGR1 DENND4B OTULINL HSPG2 CACNA2D1 FAT4 FBXW10 B4GALNT4 HDAC5 ADAMTS4 EFEMP2 GPX3 TMEM175 DNAH2 LAMA4 CRTC1 SLC6A13 ARSB CELF3 GYS1 DCHS1 PABPC1L	4.01e-06	1228	220	31	facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1	EPHB6 HDAC9 POGLUT3 EYA4 DCX GREB1L IGSF10 SEMA6D NEGR1 PTPRQ ANKRD12 ADGRL3 CACNA2D1 FAT4 SFRP1 VWF ABI3BP TMEM175 DNAH2 LAMA2 LAMA4 DEGS1 MMRN1 FRK ARSB P3H2 DCHS1 XKRX CLCF1 MYBPC1	4.01e-06	1166	220	30	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	LAMA1 ITGA4 B4GALT1 IGSF10 HOXC6 CACNA2D1 SFRP1 TNC EFEMP2 GPX3 LAMA2 MUC16 FRK P3H2	4.71e-06	310	220	14	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
CoexpressionAtlas	DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_200	EYA4 DCX HOXA1 PHEX NEGR1 OTULINL LAMA4 PTPRT MMRN1 CD36	1.17e-05	170	220	10	gudmap_developingKidney_e13.5_podocyte cells_200
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	POGLUT3 ENPP3 F3 IGSF10 NID1 HSPG2 NID2 CACNA2D1 ABI3BP ADAMTS4 TNC GPX3 LAMA2 LAMA4 CD36 CSMD1	1.76e-05	445	220	16	GSM777043_500
CoexpressionAtlas	kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200	EYA4 DCX NEGR1 AGL CACNA2D1 TNC	1.77e-05	53	220	6	gudmap_kidney_P1_CapMes_Crym_k4_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500	LAMA1 ITGA4 GREB1L IGSF10 HOXC6 NID1 ADGRL3 CACNA2D1 SFRP1 GPX3 LAMA2 MUC16 P3H2 CD36	2.24e-05	356	220	14	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	HDAC9 EYA4 TM9SF3 SRD5A2 DCX HOXA1 PTPN4 MAMDC2 DNMBP ADGRL3 TBX5 CACNA2D1 FAT4 RMND5A TNC LAMA4 TMC4 GRM7 TMEM33 ELAVL2 RBM24 CDH10	3.57e-05	806	220	22	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	kidney_P1_CapMes_Crym_top-relative-expression-ranked_200	EYA4 DCX HOXB8 HOXC6 NEGR1 AGL CACNA2D1 TNC	3.63e-05	120	220	8	gudmap_kidney_P1_CapMes_Crym_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500	HDAC9 EYA4 TM9SF3 DGKB DCX MAMDC2 ADGRL3 CACNA2D1 FAT4 RMND5A GRM7 TMEM33 ELAVL2 RBM24 CDH10	4.21e-05	427	220	15	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500
CoexpressionAtlas	Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4	NID1 COL12A1 TNC STAP2 LAMA4 MMRN1 CD36	4.51e-05	91	220	7	GSM777059_100
CoexpressionAtlas	kidney_P0_CapMes_Crym_top-relative-expression-ranked_200	EYA4 DCX HOXB8 HOXC6 NEGR1 AGL CACNA2D1 TNC	4.59e-05	124	220	8	gudmap_kidney_P0_CapMes_Crym_200
CoexpressionAtlas	dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k-means-cluster#3_top-relative-expression-ranked_1000	HDAC9 EYA4 DGKB ITGA4 DCX NRXN1 SCN9A CACNA2D1 ELAVL2 CDH10	5.12e-05	202	220	10	gudmap_dev lower uro neuro_e14.5_BladdPelvicGanglion_Sox10_k3_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	POGLUT3 LAMA1 ITGA4 B4GALT1 EPM2AIP1 GREB1L IGSF10 HOXC6 NID1 ADGRL3 CACNA2D1 SFRP1 EFEMP2 GPX3 LAMA2 MUC16 FRK P3H2 CD36 GYS1 DCHS1	5.78e-05	773	220	21	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000	HDAC9 EYA4 PACSIN3 DCX GREB1L IGSF10 TUBB4A CDH20 NRXN1 NRXN2 NEGR1 ADGRL3 CACNA2D1 VWF ABI3BP TNC DNAH2 ARSB CELF3 SLITRK5 ELAVL2 XKRX CLCF1 SEZ6	8.10e-05	976	220	24	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000
CoexpressionAtlas	kidney_P2_CapMes_Crym_top-relative-expression-ranked_200	EYA4 DCX HOXB8 HOXC6 NEGR1 CACNA2D1 TNC LAMA4	1.03e-04	139	220	8	gudmap_kidney_P2_CapMes_Crym_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	LAMA1 ITGA4 GREB1L IGSF10 HOXC6 NID1 ADGRL3 CACNA2D1 SFRP1 TNC LAMA2 MUC16 P3H2	1.07e-04	361	220	13	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#2	EPHB6 HDAC9 GPR108 COQ2 HELB CDH20 PLEC SFRP1 HDAC5 B4GAT1 P3H2	1.21e-04	269	220	11	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K2
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500	LAMA1 ITGA4 IGSF10 HOXC6 CACNA2D1 SFRP1 GPX3 LAMA2 P3H2	1.23e-04	182	220	9	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500
CoexpressionAtlas	DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#2_top-relative-expression-ranked_200	HOXA1 LAMA4 MMRN1 CD36	1.40e-04	26	220	4	gudmap_developingKidney_e13.5_podocyte cells_200_k2
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	HDAC9 LAMA1 ITGA4 GREB1L IGSF10 TUBB4A HOXC6 NID1 ADGRL3 CACNA2D1 SFRP1 ABI3BP TNC EFEMP2 GPX3 LAMA2 MUC16 FRK P3H2 DCHS1	1.79e-04	777	220	20	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500	EYA4 PACSIN3 DCX IGSF10 NRXN1 NEGR1 ADGRL3 CACNA2D1 VWF ABI3BP TNC DNAH2 ARSB XKRX CLCF1	1.89e-04	489	220	15	Facebase_RNAseq_e8.5_Paraxial Mesoderm_500
CoexpressionAtlas	kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000	HDAC9 HGD RELN LAMA1 DGKB ITGA4 F3 GGH TUBB4A HOXB8 AGL NID1 CACNA2D1 COL12A1 ABI3BP GPX3 ADAMTS8 FRK SLC6A13 P3H2 GYS1 WDFY3	1.91e-04	905	220	22	gudmap_kidney_P0_JuxtaGlom_Ren1_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500	LAMA1 GREB1L PTPN4 HOXC6 SEMA6D ADGRL3 FAT4 SFRP1 COL12A1 DSC2 MUC16 CDH10 CDH12	2.18e-04	388	220	13	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	EYA4 GALM PACSIN3 EYA2 F3 DCX IGSF10 TUBB4A NRXN1 NEGR1 SCN9A ADGRL3 CACNA2D1 VWF DSC2 ABI3BP TNC DNAH2 ARSB CELF3 ELAVL2 XKRX CLCF1	2.40e-04	984	220	23	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4	F3 IGSF10 NID1 HSPG2 NID2 DSC2 ABI3BP TNC EFEMP2 GPX3 LAMA4 P3H2 DCHS1 CSMD1	3.00e-04	455	220	14	GSM777055_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.MLN, CD11b-FITC CD4-PE CD11c-Alexa750 CD8a-PacificBlue, Lymph Node, avg-2	PI4K2B SEMA6D PLPPR4 NID1 SLC26A2 STAP2 BIRC2 BIRC3 WDR91 P3H2 CD36 SLAMF7 ANKRD33B	3.14e-04	403	220	13	GSM605834_500
CoexpressionAtlas	kidney_P1_CapMes_Crym_top-relative-expression-ranked_1000	PECR EYA4 EYA2 DCX HOXB8 HOXC6 NEGR1 AGL CACNA2D1 B4GALNT4 COL12A1 ABI3BP TNC SLC35B3 IGF1R EIF4A1 DCHS1	3.41e-04	633	220	17	gudmap_kidney_P1_CapMes_Crym_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_200	EYA4 NEGR1 CACNA2D1	3.67e-04	14	220	3	gudmap_developingKidney_e15.5_Cap mesenchyme_200_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_500	KCNF1 MAMDC2 CACNA2D1 LAMA4 CD36 RBM24	3.70e-04	91	220	6	gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k4
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	F3 IGSF10 NID1 HSPG2 SFRP1 DSC2 ABI3BP TNC EFEMP2 GPX3 LAMA2 LAMA4 DCHS1 CSMD1	3.81e-04	466	220	14	GSM777050_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	CACNA2D2 LAMA1 ITGA4 B4GALT1 GREB1L IGSF10 HOXC6 NID1 ADGRL3 CACNA2D1 SFRP1 TNC EFEMP2 GPX3 LAMA2 MUC16 FRK P3H2 FYN	4.26e-04	768	220	19	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.MLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-3	PI4K2B SEMA6D PLPPR4 NID1 SLC26A2 STAP2 BIRC2 BIRC3 WDR91 P3H2 CD36 SLAMF7 ANKRD33B	4.44e-04	418	220	13	GSM605836_500
CoexpressionAtlas	kidney_P1_CapMes_Crym_top-relative-expression-ranked_100	EYA4 DCX HOXB8 CACNA2D1 TNC	4.57e-04	62	220	5	gudmap_kidney_P1_CapMes_Crym_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	ZMYND19 PACSIN3 DGKB PTPN4 NRXN1 NRXN2 NEGR1 IQSEC1 ANKRD12 CACNA2D1 RANBP2 FAT4 DNAH2 BIRC2 NBEA CEBPZ ELAVL2	4.94e-04	654	220	17	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	IGSF10 NID1 HSPG2 ABI3BP LAMA2 LAMA4	5.21e-04	97	220	6	GSM777043_100
CoexpressionAtlas	MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05	CACNA2D2 ZNF214 EYA2 EPM2AIP1 CDH20 DENND4B CNTN5 PLCG1 ADGRL3 TBX5 CACNA2D1 FAM234B B4GALNT4 SFRP1 B4GAT1 BAZ2B USP28 GPX3 CRTC1 NBEA MMRN1 IGF1R GYS1 SLITRK5 HLTF PABPC1L	5.33e-04	1245	220	26	PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05
CoexpressionAtlas	kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200	EYA4 DCX HOXB8 NEGR1 TNC LAMA4	5.50e-04	98	220	6	gudmap_kidney_P2_CapMes_Crym_k3_200
CoexpressionAtlas	kidney_P0_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200	DCX NEGR1 AGL TNC	5.66e-04	37	220	4	gudmap_kidney_P0_CapMes_Crym_k3_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5	IGSF10 ADGRL3 CACNA2D1 VWF ABI3BP TNC DNAH2 ARSB XKRX CLCF1	6.38e-04	276	220	10	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN CATSPERD DGKB CSMD2 NRXN1 CNTN5 USH2A ADGRL3 DNAH2 GRM7 PTPRT CSMD1 CDH12	9.51e-13	146	233	13	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN MYO7B LAMA1 DGKB DCX NRXN1 PTPRQ SCN9A USH2A ADGRL3 FAT4 COL12A1 DNAH1 CSMD1	1.09e-12	184	233	14	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN MYO7B LAMA1 DGKB DCX NRXN1 PTPRQ SCN9A USH2A ADGRL3 FAT4 COL12A1 DNAH1 CSMD1	1.09e-12	184	233	14	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN MYO7B LAMA1 DGKB DCX NRXN1 PTPRQ SCN9A USH2A ADGRL3 FAT4 COL12A1 DNAH1 CSMD1	1.09e-12	184	233	14	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	MYH10 EYA2 PHEX IGSF10 PLPPR4 NID1 TBX5 ABI3BP TNC EFEMP2 LAMA4 ADAMTS8 SLC2A5 SLITRK5	3.40e-12	200	233	14	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	MYH10 EYA2 PHEX IGSF10 PLPPR4 NID1 TBX5 ABI3BP TNC EFEMP2 LAMA4 ADAMTS8 SLC2A5 SLITRK5	3.40e-12	200	233	14	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 EYA2 PHEX IGSF10 NEGR1 NID1 TBX5 ABI3BP TNC EFEMP2 GPX3 LAMA4 ADAMTS8	3.54e-11	194	233	13	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN DGKB CSMD2 GREB1L NRXN1 CNTN5 USH2A ADGRL3 GRM7 PTPRT CSMD1 CDH12	5.10e-11	159	233	12	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 LAMA1 PHEX IGSF10 NID1 TBX5 ABI3BP TNC EFEMP2 LAMA4 ADAMTS8 SLITRK5 CDH10	5.18e-11	200	233	13	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	MYH10 PHEX IGSF10 PLPPR4 MAMDC2 NID1 FAT4 ABI3BP TNC GPX3 LAMA2 LAMA4 ADAMTS8	5.18e-11	200	233	13	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYH10 PHEX IGSF10 PLPPR4 MAMDC2 NID1 FAT4 ABI3BP TNC GPX3 LAMA2 LAMA4 ADAMTS8	5.18e-11	200	233	13	a510deaada669e690329183e18df02870bd204b3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYH10 PHEX IGSF10 PLPPR4 MAMDC2 NID1 FAT4 ABI3BP TNC GPX3 LAMA2 LAMA4 ADAMTS8	5.18e-11	200	233	13	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 EYA2 PHEX NID1 TBX5 ABI3BP ADAMTS4 TNC EFEMP2 GPX3 LAMA4 ADAMTS8	4.55e-10	192	233	12	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYH10 PHEX NEGR1 MAMDC2 NID1 TBX5 CACNA2D1 ABI3BP GPX3 LAMA2 LAMA4 ADAMTS8	4.83e-10	193	233	12	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ESR1 IGSF10 NEGR1 MAMDC2 NID1 FAT4 SFRP1 COL12A1 ABI3BP GPX3 LAMA2 LAMA4	5.44e-10	195	233	12	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH10 IGSF10 PLPPR4 MAMDC2 NID1 FAT4 ABI3BP ADAMTS4 GPX3 LAMA2 LAMA4 ADAMTS8	6.11e-10	197	233	12	94a9603cbd3516fbcce871909693b88f20d41713
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYH10 LAMA1 PHEX IGSF10 NID1 NID2 ABI3BP TNC EFEMP2 LAMA4 ADAMTS8 CDH10	6.86e-10	199	233	12	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 NEGR1 MAMDC2 NID1 TBX5 FAT4 ABI3BP BAZ2B TNC LAMA2 LAMA4 ARSB	6.86e-10	199	233	12	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	3'-Parenchyma_lung-Mesenchymal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH10 NEGR1 MAMDC2 NID1 TBX5 SFRP1 ABI3BP EFEMP2 GPX3 LAMA2 LAMA4 ADAMTS8	7.27e-10	200	233	12	ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYH10 LAMA1 EYA2 PHEX NID1 TBX5 NID2 ABI3BP TNC EFEMP2 LAMA4 ADAMTS8	7.27e-10	200	233	12	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	MYH10 NEGR1 MAMDC2 NID1 TBX5 CACNA2D1 FAT4 ABI3BP TNC EFEMP2 LAMA4 ARSB	7.27e-10	200	233	12	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	MYH10 EYA2 PHEX IGSF10 PLPPR4 NID1 ABI3BP TNC LAMA4 ADAMTS8 SLC2A5 SLITRK5	7.27e-10	200	233	12	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	COVID-19-kidney-Mito-rich_Int\|kidney / Disease (COVID-19 only), tissue and cell type	RELN KCNF1 ADGRL3 LAMA2 GRM7 PTPRT CD36 CSMD1 CDH12 MYBPC1	1.64e-09	129	233	10	57b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCell	COVID-19-Heart-T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RELN CATSPERD ITGA4 NRXN1 CNTN5 SI GRM7 PTPRT CSMD1 CDH12 MYBPC1	1.81e-09	171	233	11	b2e753e811a7639956994609f73efcdb62d04f82
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NEGR1 NID1 ADGRL3 HSPG2 NID2 COL12A1 VWF ABI3BP TNC LAMA2 CD36	3.49e-09	182	233	11	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ESR1 ITGA4 NEGR1 CACNA2D1 FAT4 ABI3BP SLC26A2 LAMA2 MED13L ARSB KCTD20	3.91e-09	184	233	11	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	MYH10 PLPPR4 NEGR1 MAMDC2 NID1 TBX5 CACNA2D1 FAT4 ABI3BP LAMA2 LAMA4	4.63e-09	187	233	11	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	MYH10 B4GALT1 NID1 TBX5 CACNA2D1 ABI3BP TNC EFEMP2 GPX3 LAMA2 LAMA4	5.18e-09	189	233	11	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 EYA2 PHEX IGSF10 NID1 TBX5 ABI3BP TNC GPX3 LAMA4 ADAMTS8	6.10e-09	192	233	11	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZMYND19 EPHB6 HOXA1 IGSF10 MAMDC2 SFRP1 EFEMP2 GPX3 LAMA2 TECTA AK8	6.44e-09	193	233	11	7c0d84b92470bfda2db1e5007feee7c1235a0a78
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 EYA2 PHEX IGSF10 MAMDC2 TBX5 ABI3BP TNC GPX3 ADAMTS8 CDH10	6.44e-09	193	233	11	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	MYH10 PHEX NID1 TBX5 CACNA2D1 FAT4 ABI3BP TNC LAMA2 LAMA4 ADAMTS8	6.44e-09	193	233	11	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYH10 PHEX MAMDC2 NID1 TBX5 CACNA2D1 ABI3BP GPX3 LAMA2 LAMA4 ADAMTS8	6.80e-09	194	233	11	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 EYA2 PHEX IGSF10 TBX5 ABI3BP TNC GPX3 LAMA4 ADAMTS8 CDH10	6.80e-09	194	233	11	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	MYH10 NEGR1 MAMDC2 NID1 ADGRL3 TBX5 ABI3BP GPX3 LAMA2 LAMA4 ADAMTS8	7.17e-09	195	233	11	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D122\|Adult / Lineage, Cell type, age group and donor	MYH10 PHEX IGSF10 NEGR1 MAMDC2 NID1 TBX5 ABI3BP LAMA2 LAMA4 ADAMTS8	7.17e-09	195	233	11	aa0add081881d349099d12efca5cdee098038d4e
ToppCell	COPD-Stromal-Myofibroblast\|COPD / Disease state, Lineage and Cell class	MYH10 NID1 TBX5 FAT4 ABI3BP ADAMTS4 TNC EFEMP2 LAMA2 LAMA4 ADAMTS8	7.56e-09	196	233	11	af206bb5bbb8b604a6212acd79878bcc3d326cec
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYH10 IGSF10 NEGR1 MAMDC2 NID1 TBX5 CACNA2D1 ABI3BP LAMA2 LAMA4 ADAMTS8	7.56e-09	196	233	11	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	EYA4 PLPPR4 NEGR1 KCNF1 MAMDC2 GGPS1 TBX5 FAT4 ABI3BP LAMA2 LAMA4	7.97e-09	197	233	11	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	COPD-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	MYH10 NEGR1 NID1 TBX5 FAT4 ABI3BP ADAMTS4 TNC LAMA2 LAMA4 ADAMTS8	7.97e-09	197	233	11	d51f484b4e01ac64233950d0b97fa88825ea1dbb
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYH10 PHEX IGSF10 NEGR1 MAMDC2 NID1 ABI3BP GPX3 LAMA2 LAMA4 ADAMTS8	8.40e-09	198	233	11	f1374f7a50244d59c766ac41f44c08c9117407d2
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|367C / Donor, Lineage, Cell class and subclass (all cells)	MYH10 PHEX IGSF10 MAMDC2 TBX5 ABI3BP EFEMP2 GPX3 LAMA2 LAMA4 ADAMTS8	8.40e-09	198	233	11	a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	MYH10 PHEX IGSF10 MAMDC2 TBX5 ABI3BP EFEMP2 GPX3 LAMA2 LAMA4 ADAMTS8	8.40e-09	198	233	11	7b5350768f306ec528e271d2ac4470bf668ec6f0
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	MYH10 EYA2 PHEX IGSF10 NID1 TBX5 ABI3BP TNC EFEMP2 LAMA4 ADAMTS8	8.86e-09	199	233	11	c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SEMA6D MAMDC2 NID1 ADGRL3 FAT4 SFRP1 COL12A1 ABI3BP TNC GPX3 LAMA4	8.86e-09	199	233	11	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYH10 PHEX IGSF10 NID1 TBX5 ABI3BP TNC EFEMP2 LAMA4 ADAMTS8 SLITRK5	8.86e-09	199	233	11	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	343B-Fibroblasts-Fibroblast-G-\|343B / Donor, Lineage, Cell class and subclass (all cells)	MYH10 PHEX IGSF10 MAMDC2 TBX5 ABI3BP TNC GPX3 LAMA2 LAMA4 ADAMTS8	8.86e-09	199	233	11	9c6d1c328bfbb6547f4c7bb2a784576a56bd72af
ToppCell	343B-Fibroblasts-Fibroblast-G\|343B / Donor, Lineage, Cell class and subclass (all cells)	MYH10 PHEX IGSF10 MAMDC2 TBX5 ABI3BP TNC GPX3 LAMA2 LAMA4 ADAMTS8	8.86e-09	199	233	11	f4b6c095cbe7a38b310adc49be4069e4d56e6a66
ToppCell	medial-mesenchymal\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYH10 SEMA6D MAMDC2 NID1 TBX5 ABI3BP EFEMP2 GPX3 LAMA2 LAMA4 ADAMTS8	9.33e-09	200	233	11	4f19e1e40966e27779bf77e8c170ed3ecc24353e
ToppCell	medial-2-mesenchymal\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYH10 SEMA6D MAMDC2 NID1 TBX5 ABI3BP EFEMP2 GPX3 LAMA2 LAMA4 ADAMTS8	9.33e-09	200	233	11	a9d8aa5bcf383d98a9e2eaf4b1f8466982d6b088
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	F3 NEGR1 MAMDC2 NID1 SFRP1 COL12A1 ABI3BP EFEMP2 GPX3 LAMA2 LAMA4	9.33e-09	200	233	11	933b5b400e48a511ba0a056be1d33d3610b5f10d
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	MYH10 NEGR1 MAMDC2 NID1 TBX5 ABI3BP BAZ2B TNC LAMA2 LAMA4 NBEA	9.33e-09	200	233	11	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN CATSPERD GREB1L NRXN1 CNTN5 USH2A ADGRL3 GRM7 PTPRT CDH12	1.58e-08	163	233	10	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POGLUT3 GGH PTPN4 CDH20 ABI3BP ACTR3B SLC6A13 IGF1R RBM24 CDH10	3.64e-08	178	233	10	408e41c853f608965cef9111fb87fdc311cdc7a8
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CSMD2 PRDM8 CDH20 CNTN5 SCN9A GPX3 LAMA2 LAMA4 GRM7 ANKRD33B	4.98e-08	184	233	10	6475a43201b136dcc9b113d2ca4cfa154ed9d65d
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN EYA4 LAMA1 IGSF10 ZFYVE9 NRXN1 MAMDC2 CACNA2D1 ABI3BP TNC	5.24e-08	185	233	10	f814ec9d4ade717a0109398e9768d0d66f09317b
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN EYA4 LAMA1 IGSF10 ZFYVE9 NRXN1 MAMDC2 CACNA2D1 ABI3BP TNC	5.24e-08	185	233	10	40e958511790e84321da5ccf735f9974c06a0263
ToppCell	droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN EYA4 LAMA1 IGSF10 ZFYVE9 NRXN1 MAMDC2 CACNA2D1 ABI3BP TNC	5.24e-08	185	233	10	5f2eeba80aff145e85cfd81e2890a155406badb9
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	RELN NRXN1 CNTN5 USH2A ADGRL3 MUC16 GRM7 PTPRT CDH12	5.25e-08	139	233	9	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH10 IGSF10 HOXC6 PLPPR4 MAMDC2 ABI3BP ADAMTS4 LAMA2 LAMA4 ADAMTS8	5.51e-08	186	233	10	5473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Myofibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 HOXB8 DNMBP TBX5 LAMA4 P3H2 SLITRK5 DCHS1 CSMD1 PAQR3	5.51e-08	186	233	10	cd6502bbf9dce318fdbb4965d49df8951e5f795c
ToppCell	droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 HOXB8 DNMBP TBX5 LAMA4 P3H2 SLITRK5 DCHS1 CSMD1 PAQR3	5.51e-08	186	233	10	b58db5abdd3e9f0214b198c3cbd09b0b3c321eab
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	SEMA6D PLPPR4 ADGRL3 CACNA2D1 COL12A1 ADAMTS4 TNC LAMA2 LAMA4 ANKRD33B	5.51e-08	186	233	10	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ENPP3 IGSF10 HOXB8 TBX5 LAMA4 P3H2 SLITRK5 DCHS1 CSMD1 PAQR3	5.80e-08	187	233	10	8bd635abdee5d5a12a3f7bf74eab4282e8e40741
ToppCell	droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ENPP3 IGSF10 HOXB8 TBX5 LAMA4 P3H2 SLITRK5 DCHS1 CSMD1 PAQR3	5.80e-08	187	233	10	3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	EYA4 SEMA6D PLPPR4 TBX5 CACNA2D1 FAT4 B4GALNT4 COL12A1 TNC LAMA2	6.41e-08	189	233	10	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 EYA2 PHEX IGSF10 TBX5 ABI3BP TNC GPX3 LAMA4 ADAMTS8	7.08e-08	191	233	10	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYH10 NEGR1 MAMDC2 NID1 TBX5 FAT4 ABI3BP LAMA2 LAMA4 ADAMTS8	7.08e-08	191	233	10	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYH10 IGSF10 NEGR1 MAMDC2 ABI3BP TNC GPX3 LAMA2 LAMA4 ADAMTS8	7.08e-08	191	233	10	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RELN DGKB PHEX NRXN1 CNTN5 NID2 SFRP1 COL12A1 GRM7 P3H2	7.08e-08	191	233	10	156b467187331ac6ca390d6ca861d9670bb7b956
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	MYH10 IGSF10 NEGR1 MAMDC2 ABI3BP TNC GPX3 LAMA2 LAMA4 ADAMTS8	7.08e-08	191	233	10	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	droplet-Lung-30m-Mesenchymal\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH10 F3 IGSF10 MAMDC2 TBX5 CACNA2D1 SFRP1 LAMA2 LAMA4 ADAMTS8	7.43e-08	192	233	10	5d5bec238b196f0b3e727fd94f078d6ae524cb01
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 EYA2 PHEX IGSF10 TBX5 ABI3BP TNC EFEMP2 GPX3 ADAMTS8	7.43e-08	192	233	10	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 EYA2 PHEX IGSF10 TBX5 ABI3BP TNC EFEMP2 GPX3 ADAMTS8	7.43e-08	192	233	10	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 EYA2 PHEX IGSF10 TBX5 ABI3BP TNC GPX3 ADAMTS8 CDH10	7.43e-08	192	233	10	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 F3 GREB1L NEGR1 MAMDC2 NID1 COL12A1 ABI3BP LAMA2 SLITRK5	7.80e-08	193	233	10	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2\|World / Primary Cells by Cluster	RELN CACNA2D2 DGKB DCX NRXN1 NRXN2 SCN9A ANKRD12 PTPRT ELAVL2	8.19e-08	194	233	10	b42fd64b0fb95434a9e4e6586f31d26114a4074b
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10\|World / Primary Cells by Cluster	RELN CACNA2D2 DGKB DCX NRXN1 NRXN2 SCN9A ANKRD12 PTPRT ELAVL2	8.19e-08	194	233	10	81e7bc6516ab8d02ccd1c76a56a3533b788c27c8
ToppCell	Control-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	MYH10 NEGR1 NID1 TBX5 ABI3BP TNC GPX3 LAMA2 LAMA4 ADAMTS8	8.19e-08	194	233	10	3c2266772c5b56e8e02a461e5193e29588028ee9
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 EYA2 PHEX IGSF10 TBX5 ABI3BP TNC GPX3 LAMA4 ADAMTS8	8.19e-08	194	233	10	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	(5)_Fibroblast-C_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MYH10 PHEX IGSF10 PLPPR4 MAMDC2 TBX5 ABI3BP EFEMP2 LAMA2 LAMA4	8.19e-08	194	233	10	29a72e565c19407bbd198cfbc2a78106fe830d05
ToppCell	Control-Stromal-Myofibroblast\|Control / Disease state, Lineage and Cell class	MYH10 NEGR1 NID1 TBX5 ABI3BP TNC EFEMP2 LAMA2 LAMA4 ADAMTS8	8.59e-08	195	233	10	ffcf76cd72e43d8cf1058a49c76e0956065038bc
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POGLUT3 F3 IGSF10 NID1 HSPG2 SFRP1 ABI3BP EFEMP2 GPX3 LAMA2	8.59e-08	195	233	10	69a29d03e664b72f32d41876510c62345c3aed31
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH10 IGSF10 NEGR1 MAMDC2 NID1 ABI3BP GPX3 LAMA2 LAMA4 ADAMTS8	8.59e-08	195	233	10	df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell\|Adult / Lineage, Cell type, age group and donor	MYH10 PHEX NEGR1 MAMDC2 NID1 TBX5 ABI3BP LAMA2 LAMA4 ADAMTS8	8.59e-08	195	233	10	61c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH10 IGSF10 NEGR1 MAMDC2 NID1 ABI3BP GPX3 LAMA2 LAMA4 ADAMTS8	8.59e-08	195	233	10	4243190ad291d56694e2155954dbaa879c9d3844
ToppCell	facs-GAT-Fat-3m-Mesenchymal\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POGLUT3 F3 IGSF10 NID1 HSPG2 SFRP1 ABI3BP EFEMP2 GPX3 LAMA2	8.59e-08	195	233	10	1cffae2b08dbfa1c633ce24023e89b66d28b5431
ToppCell	facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POGLUT3 F3 IGSF10 NID1 HSPG2 SFRP1 ABI3BP EFEMP2 GPX3 LAMA2	8.59e-08	195	233	10	9cef6f18664518060af7c192310dddce6d70345a
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RELN DGKB CSMD2 NRXN1 CNTN5 USH2A GRM7 PTPRT CDH12	9.01e-08	148	233	9	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH10 IGSF10 NEGR1 MAMDC2 NID1 ABI3BP GPX3 LAMA2 LAMA4 ADAMTS8	9.01e-08	196	233	10	42e9828222a9663525d571633e8a454c30bfa7f8
ToppCell	Control-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	F3 NEGR1 NID1 SFRP1 COL12A1 ABI3BP ADAMTS4 GPX3 LAMA2 LAMA4	9.01e-08	196	233	10	1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH10 MAMDC2 NID1 TBX5 FAT4 ABI3BP GPX3 LAMA2 LAMA4 GRM7	9.45e-08	197	233	10	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	MYH10 NEGR1 MAMDC2 NID1 TBX5 ABI3BP GPX3 LAMA2 LAMA4 ADAMTS8	9.91e-08	198	233	10	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	MYH10 NEGR1 MAMDC2 NID1 TBX5 CACNA2D1 ABI3BP GPX3 LAMA2 LAMA4	9.91e-08	198	233	10	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYH10 HOXC6 MAMDC2 NID1 ADGRL3 FAT4 COL12A1 TNC GPX3 LAMA4	9.91e-08	198	233	10	7582ee9ec8a87ecb094201f1f9191b412f9d2875
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	HDAC9 DGKB NEGR1 NID1 ADGRL3 TBX5 ADAMTS4 LAMA4 ELAVL2 RBM24	9.91e-08	198	233	10	c12e7511628db819a52959bb68580e27c00c2e41
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NID1 TM4SF18 HSPG2 NID2 COL12A1 VWF LAMA4 MMRN1 BARHL1 NR5A2	1.04e-07	199	233	10	9c40b3ee39860e9d8edafd007daec11abdd95435
ToppCell	LPS_only-Mesenchymal_fibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	MYH10 EYA2 PHEX NID2 ABI3BP TNC EFEMP2 GPX3 LAMA4 ADAMTS8	1.04e-07	199	233	10	211c3a08f2d484ab7a3368006767289088f0d957
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NID1 TM4SF18 HSPG2 NID2 COL12A1 VWF LAMA4 MMRN1 BARHL1 NR5A2	1.04e-07	199	233	10	72b34bce8157abe389e95cd3ed8ba578dce0cbf6
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	MYH10 PLPPR4 MAMDC2 NID1 NID2 ABI3BP TNC LAMA2 LAMA4 ADAMTS8	1.04e-07	199	233	10	7a227c239afdaebcac84644d9b2653a5f1a4be71
Computational	Adhesion molecules.	RELN NID1 COL12A1 VWF TNC EFEMP2 LAMA2 LAMA4 MMRN1	8.14e-05	141	138	9	MODULE_122
Drug	kalinin	LAMA1 ITGA4 NID1 PLEC HSPG2 TNC LAMA2 LAMA4	7.26e-08	55	228	8	CID000032518
Drug	sulfate	EPHB6 GALM ARSK ENPP3 ESR1 LAMA1 SRI OTOL1 F3 PTPN4 GLUD1 GLUD2 FES NID1 PLCG1 PLEC GGPS1 HSPD1 HSPG2 CACNA2D1 VWF TNC SLC26A2 SLC35B3 LAMA2 LAMA4 CTSA DEGS1 IGF1R ARSB CD36 CD69 MAPK1	7.20e-07	1292	228	33	CID000001117
Drug	PQ 401	IGF1R MAPK1 MAPK3	9.91e-07	3	228	3	ctd:C569479
Drug	tyrphostin AG 1024	ESR1 IGF1R MAPK1 MAPK3	1.19e-06	9	228	4	ctd:C447031
Drug	YIGSR	HGD PECR LAMA1 ITGA4 TUBB4A NID1 LAMA2 LAMA4	1.27e-06	79	228	8	CID000123977
Drug	butylparaben	RELN CACNA2D2 ESR1 NRXN1 NRXN2 CACNA2D1 IGF1R MAPK1 MAPK3 FYN	4.32e-06	157	228	10	ctd:C038091
Drug	Rgd Peptide	ITGA4 TUBB4A NID1 COL12A1 VWF TNC LAMA4 CD36 DCHS1 ADAM2 MAPK1 MAPK3	5.67e-06	239	228	12	CID000104802
Drug	DB04780	ARSK F3 HSPD1 NID2 VWF LAMA4 ADAMTS8 CTSA DEGS1 ARSB	8.74e-06	170	228	10	CID005459389
Drug	tibolone	ESR1 F3 MAPK1 MAPK3	9.06e-06	14	228	4	ctd:C027385
Drug	tamibarotene	MYH10 ESR1 SRI ITGA4 F3 GLUD2 FES LILRA3 RMND5A SLC26A2 GLOD4 CTSA SLC2A5 CD36 CD69 MAPK1 MAPK3 FYN ATP6V0A2	9.82e-06	596	228	19	ctd:C061133
Drug	ethyl acetate	HSPD1 GRM6 CTSA GRM7 DEGS1 MAPK1 MAPK3 SLAMF7 CDH12	1.02e-05	137	228	9	CID000008857
Drug	glyceollin	ESR1 GLUD1 GLUD2 GGPS1	1.62e-05	16	228	4	CID000162807
Drug	4-Aminopyridine	HDAC5 BIRC2 BIRC3 MAPK1 MAPK3	1.82e-05	33	228	5	ctd:D015761
Drug	4-hydroxy-N-desmethyltamoxifen	ESR1 MAPK1 MAPK3	1.94e-05	6	228	3	ctd:C055492
Drug	malvidin-3-O-glucoside-4 vinyl	PLCG1 MAPK1 MAPK3	1.94e-05	6	228	3	ctd:C480486
Drug	BMS 536924	IGF1R MAPK1 MAPK3	1.94e-05	6	228	3	ctd:C504983
Drug	picrotoxinin	ESR1 MAPK1 MAPK3	1.94e-05	6	228	3	ctd:C022961
Drug	LY 117018	ESR1 MAPK1 MAPK3	1.94e-05	6	228	3	ctd:C025430
Drug	5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol	ESR1 MAPK1 MAPK3	1.94e-05	6	228	3	ctd:C120076
Drug	ampelopsin	PLCG1 MAPK1 MAPK3	1.94e-05	6	228	3	ctd:C106407
Drug	isodiazinon	GLUD1 FECH GLUD2	1.94e-05	6	228	3	CID000133913
Drug	lifarizine	GLUD1 GLUD2 SCN9A CACNA2D1	2.10e-05	17	228	4	CID000071336
Drug	evodiamine	PLCG1 BIRC2 BIRC3 MAPK1 MAPK3	2.12e-05	34	228	5	ctd:C049639
Drug	AFFIRM	HGD HELB SI NLRP2 TG CD69 MAPK3	2.73e-05	87	228	7	CID006435890
Drug	Fenoldopam	ENPP3 B4GALT1 COL12A1 VWF ADAMTS4 TNC	2.73e-05	59	228	6	ctd:D018818
Drug	Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; HL60; HT_HG-U133A	MYH10 ESR1 LILRB1 STK11 ZFYVE9 ABI3BP PKD2L1 CRTC1 SLC6A13 SLAMF7	3.14e-05	197	228	10	2468_UP
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A	HDAC9 CACNA2D2 ZNF214 NID1 TBX5 PCDHGA10 LAMA2 TECTA SLC2A5 NR5A2	3.14e-05	197	228	10	5685_UP
Drug	Equilin [474-86-2]; Up 200; 15uM; HL60; HT_HG-U133A	RELN ESR1 PACSIN3 HOXA1 SEMA6D DNMBP TBX5 DNAH2 SI CDH10	3.14e-05	197	228	10	3039_UP
Drug	Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; MCF7; HT_HG-U133A	RELN GREB1L ZFYVE9 HDAC5 DSC2 TNC NLRP2 SLC6A13 IGF1R WDFY3	3.27e-05	198	228	10	2768_UP
Drug	(-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; MCF7; HT_HG-U133A	ESR1 HOXA1 ZFYVE9 PIGR FECH CACNA2D1 RMND5A HDAC5 DSC2 CRTC1	3.27e-05	198	228	10	2772_UP
Drug	N,N'-diphenyl-4-phenylenediamine	ESR1 MAPK1 MAPK3	3.37e-05	7	228	3	ctd:C004845
Drug	vitisin A	PLCG1 MAPK1 MAPK3	3.37e-05	7	228	3	ctd:C412469
Drug	4-ethylphenol	ESR1 MAPK1 MAPK3	3.37e-05	7	228	3	ctd:C042291
Drug	lercanidipine	ESR1 MAPK1 MAPK3	3.37e-05	7	228	3	ctd:C060343
Drug	CHEBI:564108	ENPP3 F3 CACNA2D1	3.37e-05	7	228	3	CID006400637
Drug	hydroxyflutamide	ESR1 SRD5A2 MAPK1 MAPK3	3.37e-05	19	228	4	ctd:C014290
Drug	Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; HL60; HT_HG-U133A	B4GALT1 PHEX ZFYVE9 KCNF1 IQSEC1 EFEMP2 BIRC3 ADAMTS8 SLITRK5 CD69	3.42e-05	199	228	10	2563_UP
Drug	Pyrimethamine [58-14-0]; Up 200; 16uM; MCF7; HT_HG-U133A	RELN ADAM18 ESR1 SRI CUL9 B4GALT1 EFEMP2 CRTC1 SLC2A5 CLCF1	3.57e-05	200	228	10	1474_UP
Drug	enzacamene	RELN CACNA2D2 ESR1 NRXN1 NRXN2 CACNA2D1 IGF1R FYN	4.82e-05	129	228	8	ctd:C038939
Drug	manganese	ZMPSTE24 CACNA2D2 ENPP3 LAMA1 ITGA4 B4GALT1 TUBB4A ZFYVE9 FECH FES GGPS1 CACNA2D1 VWF B4GAT1 LAMA2 LAMA4 GYS1 LTA ADAM2 MAPK1 MAPK3	5.04e-05	791	228	21	CID000023930
Drug	malonate	COQ2 LDB1 NEGR1 GLUD1 GLUD2 SLC26A2 GRM6 GRM7 DEGS1 MMRN1	5.17e-05	209	228	10	CID000000867
Drug	CDRI 85-287	ESR1 MAPK1 MAPK3	5.35e-05	8	228	3	ctd:C066624
Drug	Dichlorodiphenyl Dichloroethylene	RELN ESR1 SRD5A2 NRXN1 NRXN2 TG MMRN1 IGF1R CD36 MAPK1 MAPK3 FYN	5.74e-05	302	228	12	ctd:D003633
Drug	lactate	EPHB6 HGD GALM ARID4B COQ2 GGH PTPN4 AGL GLUD1 GLUD2 SCN9A HSPD1 IL31RA AK8 GYS1	6.89e-05	461	228	15	CID000000612
Drug	chondroitin sulfate	EPHB6 ARSK ITGA4 F3 NID1 HSPG2 COL12A1 ADAMTS4 TNC SLC26A2 LAMA4 MMRN1 ARSB CD36	7.82e-05	413	228	14	CID000024766
Drug	farrerol	ESR1 MAPK1 MAPK3	7.96e-05	9	228	3	ctd:C015881
Drug	4-(2-phenyl-5,7-bis(trifluoromethyl)pyrazolo(1,5-a)pyrimidin-3-yl)phenol	ESR1 MAPK1 MAPK3	7.96e-05	9	228	3	ctd:C556295
Drug	4-hydroxymercuribenzoate	GGH MAPK1 MAPK3	7.96e-05	9	228	3	ctd:C030601
Drug	2'-fluoro-6,7-methylenedioxy-2-phenyl-4-quinolone	IGF1R MAPK1 MAPK3	7.96e-05	9	228	3	ctd:C525063
Drug	adipamide	GLUD1 GLUD2 TG	7.96e-05	9	228	3	CID000012364
Drug	octylmethoxycinnamate	RELN CACNA2D2 ESR1 NRXN1 NRXN2 CACNA2D1 IGF1R FYN	8.18e-05	139	228	8	ctd:C118580
Drug	temsirolimus	ESR1 F3 MAPK1 MAPK3	8.89e-05	24	228	4	ctd:C401859
Drug	AC1L1KMJ	LAMA1 ITGA4 TUBB4A PLCG1 PLEC HSPD1 COL12A1 VWF LAMA2 LAMA4 ACTR3 CD36 MAPK1 MAPK3 FYN	9.83e-05	476	228	15	CID000030956
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	ESR1 MCM4 ZFYVE9 LDB1 PLEC ABI3BP BAZ2B TNC BIRC3	9.96e-05	183	228	9	7088_DN
Drug	phenyltriethoxysilane	GLUD1 GLUD2	9.98e-05	2	228	2	CID000013075
Drug	N-acetyl glycine cysteine amide	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C510898
Drug	N-acetyl-Cys-Gly-Pro-Cys-amide	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C510899
Drug	cysteinyl-leukotriene	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C112381
Drug	bromoacetyl bromide	F3 TG	9.98e-05	2	228	2	CID000061147
Drug	NP00111	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C530042
Drug	substance P (6-11), Tyr(6)-D-Phe(7)-D-His(9)-	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C496429
Drug	7-methyljuglone	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C517013
Drug	sodium tetrasulfide	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C519323
Drug	G-3SH	GLUD1 GLUD2	9.98e-05	2	228	2	CID000174237
Drug	iodoacetyldiethylstilbestrol	GLUD1 GLUD2	9.98e-05	2	228	2	CID006455327
Drug	2,2',4,4',5,5'-hexabrominated diphenyl ether	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C478854
Drug	DS-201	CACNA2D1 MAPK3	9.98e-05	2	228	2	CID000125782
Drug	MBEBP	ESR1 F3	9.98e-05	2	228	2	CID000006928
Drug	CGP 56999A	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C102659
Drug	AG 127	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C069028
Drug	methylmercuric bromide	GLUD1 GLUD2	9.98e-05	2	228	2	CID000068175
Drug	5-methylisophthalate	GLUD1 GLUD2	9.98e-05	2	228	2	CID000068137
Drug	NF023	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C105374
Drug	tyrphostin 51	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C118515
Drug	L 759656	MAPK1 MAPK3	9.98e-05	2	228	2	ctd:C118949
Drug	x 1 s	GLUD1 GLUD2	9.98e-05	2	228	2	CID000409694
Drug	AC1O3HPM	F3 SLAMF7	9.98e-05	2	228	2	CID006328862
Drug	AC1L1KZZ	HDAC9 HSPD1 BIRC2 BIRC3 MAPK3	1.05e-04	47	228	5	CID000005725
Drug	indole-3-pyruvic acid	GLUD1 GLUD2 GGPS1 IL31RA	1.05e-04	25	228	4	CID000000803
Drug	Androgen Antagonists	RELN CACNA2D2 NRXN1 NRXN2 CACNA2D1 IGF1R	1.07e-04	75	228	6	ctd:D000726
Drug	AC1L3X9S	TG IGF1R MAPK3	1.13e-04	10	228	3	CID000123777
Drug	Vanadates	HDAC9 EYA4 ARSK ESR1 LAMA1 ZNF214 AK9 ITGA4 PHEX NEGR1 SCN9A NID1 DNMBP HSPG2 ENPP7 IL31RA SFRP1 DSC2 ABI3BP TNC GPX3 BIRC3 SLC2A5 TG ARSB MAPK1 MAPK3 CDH10	1.16e-04	1302	228	28	ctd:D014638
Drug	Neomycin	HSPD1 NR5A2 MAPK1 MAPK3	1.23e-04	26	228	4	ctd:D009355
Drug	oxypertine	RELN ITGA4 TUBB4A VWF LTA	1.28e-04	49	228	5	CID000004640
Drug	Cyclophosphamide	MYH10 ESR1 F3 HOXA1 PIGR AGL NID1 HSPD1 FAM234B GPX3 BIRC3 GLOD4 MED13L CD69 MAPK1 MAPK3 FYN	1.42e-04	607	228	17	ctd:D003520
Drug	AG 1879	RELN ESR1 BIRC3 IGF1R MAPK1 MAPK3 FYN	1.45e-04	113	228	7	ctd:C412373
Drug	AC1L1G72	LAMA1 LAMA2 LAMA4	1.54e-04	11	228	3	CID000003553
Drug	4-propylphenol	ESR1 MAPK1 MAPK3	1.54e-04	11	228	3	ctd:C099327
Drug	2,3,3',4,4',5-hexachlorobiphenyl	ESR1 MAPK1 MAPK3	1.54e-04	11	228	3	ctd:C087667
Drug	HBTU	F3 HSPD1 HDAC5	1.54e-04	11	228	3	CID002733084
Drug	ICI 164384	ESR1 MAPK1 MAPK3	1.54e-04	11	228	3	ctd:C051781
Drug	BI D1870	STK11 MAPK1 MAPK3	1.54e-04	11	228	3	ctd:C516541
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A	EPHB6 EYA4 EPPK1 CUL7 RHOBTB2 DENND4B PLCG1 HDAC5 DSC2	1.61e-04	195	228	9	5117_DN
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	MYH10 PACSIN3 HOXA1 ANKRD12 GGPS1 HSPG2 RMND5A DSC2 MED13L	1.61e-04	195	228	9	6918_UP
Drug	Amoxicillin [26787-78-0]; Down 200; 11uM; PC3; HT_HG-U133A	PECR CUL7 F3 OTULINL FAM234B HDAC5 SLITRK5 WDFY3 MAPK3	1.61e-04	195	228	9	6285_DN
Drug	4-hydroxyestradiol	ESR1 IGF1R MAPK1 MAPK3	1.66e-04	28	228	4	ctd:C014036
Drug	Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A	LILRB1 GREB1L PHEX ZFYVE9 RHOBTB2 TBX5 HSPG2 ABI3BP EFEMP2	1.67e-04	196	228	9	1515_UP
Drug	Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; MCF7; HT_HG-U133A	GREB1L CACNA2D1 FAT4 PCDHGA10 DNAH2 BIRC3 GRM6 SLC6A13 P3H2	1.67e-04	196	228	9	6042_UP
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A	ESR1 F3 B4GALT1 STK11 FOXI1 SLC26A2 EFEMP2 TLR5 WDFY3	1.67e-04	196	228	9	2314_DN
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	ESR1 MCM4 LDB1 KCNF1 PLCG1 PLEC ACTR3B CEBPZ TLR5	1.67e-04	196	228	9	7183_DN
Disease	Subfertility, Female	CACNA2D2 ESR1 NR5A2 MAPK1 MAPK3	2.34e-06	28	230	5	C0341869
Disease	Sterility, Postpartum	CACNA2D2 ESR1 NR5A2 MAPK1 MAPK3	2.34e-06	28	230	5	C0038279
Disease	Female sterility	CACNA2D2 ESR1 NR5A2 MAPK1 MAPK3	2.34e-06	28	230	5	C0917730
Disease	Female infertility	CACNA2D2 ESR1 NR5A2 MAPK1 MAPK3	2.34e-06	28	230	5	C0021361
Disease	renal cell carcinoma	POGLUT3 MYO7B RHOBTB2 CRTC1 FYN	1.85e-05	42	230	5	EFO_0000681
Disease	Depressive disorder	HDAC9 RELN ESR1 DGKB CSMD2 NRXN1 SFRP1 HDAC5 GRM7 TG MAPK3	1.85e-05	289	230	11	C0011581
Disease	unipolar depression	GALM CATSPERD ESR1 DGKB AK9 SEMA6D NRXN1 NEGR1 CNTN5 PLCG1 DNAH6 CACNA2D1 LILRA1 B4GALNT4 TNC ACTR3B GRM7 AK8 SLFN12L ARSB CD36 DCHS1 ELAVL2 CSMD1	2.71e-05	1206	230	24	EFO_0003761
Disease	Mental Depression	HDAC9 RELN ESR1 DGKB CSMD2 NRXN1 SFRP1 HDAC5 GRM7 MAPK3	3.35e-05	254	230	10	C0011570
Disease	Alzheimer's disease (is_marker_for)	RELN GLUD1 PLCG1 HSPD1 IGF1R BARHL1 CD36 ADAM2 MAPK1 FYN	3.70e-05	257	230	10	DOID:10652 (is_marker_for)
Disease	severe acute respiratory syndrome, COVID-19	RELN CATSPERD RBM26 DGKB CCDC178 PTPN4 NRXN1 ADGRL3 CACNA2D1 CRTC1 GRM7 TG CSMD1	5.47e-05	447	230	13	EFO_0000694, MONDO_0100096
Disease	Van Maldergem Wetzburger Verloes syndrome	FAT4 DCHS1	6.05e-05	2	230	2	C1832390
Disease	Van Maldergem syndrome	FAT4 DCHS1	6.05e-05	2	230	2	cv:C1832390
Disease	macular degeneration (implicated_via_orthology)	CD36 PRDM13	6.05e-05	2	230	2	DOID:4448 (implicated_via_orthology)
Disease	Periventricular gray matter heterotopia	FAT4 DCHS1	6.05e-05	2	230	2	C1849173
Disease	von Willebrand's disease (is_implicated_in)	F3 VWF	6.05e-05	2	230	2	DOID:12531 (is_implicated_in)
Disease	response to lithium ion	HDAC9 CSMD2 CNTN5 COL12A1 RBM24	7.61e-05	56	230	5	GO_0010226
Disease	Ischemic stroke, von Willebrand factor measurement	HDAC9 VWF AK8 BARHL1	8.40e-05	30	230	4	EFO_0004629, HP_0002140
Disease	gallbladder carcinoma (is_marker_for)	GPX3 BIRC3 ACTR3	9.76e-05	12	230	3	DOID:4948 (is_marker_for)
Disease	hearing impairment	EYA4 CACNA2D2 USH2A FOXI1 TECTA ARSB	1.22e-04	98	230	6	C1384666
Disease	type 2 diabetes mellitus (implicated_via_orthology)	ZMPSTE24 ADAMTS4 ADAMTS8 IGF1R MAPK1 MAPK3	1.78e-04	105	230	6	DOID:9352 (implicated_via_orthology)
Disease	Heterotopia, Periventricular, Autosomal Recessive	FAT4 DCHS1	1.81e-04	3	230	2	C1842563
Disease	fascioliasis (biomarker_via_orthology)	GLUD1 GLUD2	1.81e-04	3	230	2	DOID:885 (biomarker_via_orthology)
Disease	myeloid neoplasm (is_marker_for)	F3 CD36	1.81e-04	3	230	2	DOID:0070004 (is_marker_for)
Disease	leukocyte immunoglobulin-like receptor subfamily B member 1 measurement	LILRB1 B4GALT1 LILRA1	1.98e-04	15	230	3	EFO_0008208
Disease	Schizophrenia	PI4K2B HDAC9 RELN ESR1 SRD5A2 LAMA1 CSMD2 LILRB1 NRXN1 NRXN2 LAMA2 GRM7 ELAVL2 LTA MAPK1 MAPK3 CSMD1 FYN	2.12e-04	883	230	18	C0036341
Disease	Autistic Disorder	RELN ITGA4 CUL7 HOXA1 NRXN1 NRXN2 NBEA MAPK3 CDH10	2.24e-04	261	230	9	C0004352
Disease	Craniofacial Abnormalities	ZMPSTE24 HOXA1 PHEX NRXN1 FOXI1 HSPG2 SLC26A2	2.32e-04	156	230	7	C0376634
Disease	Astrocytosis	ITGA4 MAPK1 MAPK3	2.93e-04	17	230	3	C3887640
Disease	Gliosis	ITGA4 MAPK1 MAPK3	2.93e-04	17	230	3	C0017639
Disease	obesity (implicated_via_orthology)	ESR1 FAT4 ADAMTS4 ADAMTS8 MED13L DEGS1 CD36 DCHS1	3.01e-04	215	230	8	DOID:9970 (implicated_via_orthology)
Disease	amino acid measurement	MYH10 GALM PTDSS1 DGKB NEK3 CNTN5 GLUD1 CACNA2D1 FAT4 VWF GRM7 MMRN1 SLC6A13 ELAVL2 CSMD1	3.06e-04	678	230	15	EFO_0005134
Disease	facial morphology measurement	HDAC9 EYA4 EYA2 PTPN12 NID1 NID2 FAT4 GRM7 PTPRT P3H2 ELAVL2 CSMD1	3.23e-04	466	230	12	EFO_0007841
Disease	von Willebrand factor measurement, coronary artery disease	HDAC9 PRDM8 VWF AK8 BARHL1 MAD2L1	3.35e-04	118	230	6	EFO_0001645, EFO_0004629
Disease	nidogen-2 measurement	NID1 NID2	3.59e-04	4	230	2	EFO_0020608
Disease	schizophrenia (is_marker_for)	RELN VWF ACTR3 MAPK3	3.82e-04	44	230	4	DOID:5419 (is_marker_for)
Disease	Bipolar Disorder	RELN ESR1 DGKB NRXN1 PLCG1 SFRP1 HDAC5 GRM7 SLC6A13 MAPK1 CSMD1 FYN	3.98e-04	477	230	12	C0005586
Disease	carotid artery disease (is_marker_for)	HSPD1 HSPG2 VWF	4.13e-04	19	230	3	DOID:3407 (is_marker_for)
Disease	acylcarnitine measurement	CACNA2D2 PIGR FECH USH2A PKD2L1 PTPRT	4.96e-04	127	230	6	EFO_0005059
Disease	Autism Spectrum Disorders	RELN NRXN1 NRXN2 USH2A CDH10	5.44e-04	85	230	5	C1510586
Disease	Cutis laxa, autosomal recessive	EFEMP2 ATP6V0A2	5.96e-04	5	230	2	cv:C3665335
Disease	bitter alcoholic beverage consumption measurement	RELN NRXN2 NEGR1 DNAH2 MMRN1 CSMD1	6.33e-04	133	230	6	EFO_0010092
Disease	Global developmental delay	CACNA2D2 RHOBTB2 IQSEC1 NBEA DEGS1 IGF1R	6.33e-04	133	230	6	C0557874
Disease	Septicemia	LTA MAPK1 MAPK3	8.38e-04	24	230	3	C0036690
Disease	Sepsis	LTA MAPK1 MAPK3	8.38e-04	24	230	3	C0243026
Disease	Severe Sepsis	LTA MAPK1 MAPK3	8.38e-04	24	230	3	C1719672
Disease	Pyemia	LTA MAPK1 MAPK3	8.38e-04	24	230	3	C0034189
Disease	childhood absence epilepsy (biomarker_via_orthology)	GLUD1 GLUD2	8.89e-04	6	230	2	DOID:1825 (biomarker_via_orthology)
Disease	Lissencephaly	RELN DCX	8.89e-04	6	230	2	cv:C0266463
Disease	Obsessive-Compulsive Disorder	HOXB8 SLITRK5	8.89e-04	6	230	2	C0028768
Disease	Fibroid Tumor	ESR1 SFRP1	8.89e-04	6	230	2	C0023267
Disease	CEROID LIPOFUSCINOSIS, NEURONAL, 6	MAPK1 MAPK3	8.89e-04	6	230	2	C1866282
Disease	Streptococcal pneumonia	MAPK1 MAPK3	8.89e-04	6	230	2	C0155862
Disease	osteoarthritis biomarker measurement	CRTC1 CSMD1	8.89e-04	6	230	2	EFO_0005890
Disease	Malformation of cortical development	RELN DCX	8.89e-04	6	230	2	cv:C1955869
Disease	eye disease (implicated_via_orthology)	EYA4 EYA2	8.89e-04	6	230	2	DOID:5614 (implicated_via_orthology)
Disease	Impaired glucose tolerance	FRK CD36 NR5A2	9.47e-04	25	230	3	C0271650
Disease	Ataxia	CACNA2D2 UROC1 TUBB4A	9.47e-04	25	230	3	C0004134
Disease	response to venlafaxine	CSMD2 NEGR1 COL12A1	9.47e-04	25	230	3	EFO_0006328
Disease	factor VIII measurement, von Willebrand factor measurement	VWF AK8 BARHL1	1.19e-03	27	230	3	EFO_0004629, EFO_0004630
Disease	Uterine Fibroids	ESR1 SFRP1	1.24e-03	7	230	2	C0042133
Disease	Hyperammonemia	GLUD1 TLR5	1.24e-03	7	230	2	C0220994
Disease	remission	HSPG2 FYN	1.24e-03	7	230	2	EFO_0009785
Disease	endometrial adenocarcinoma (is_implicated_in)	MAPK1 MAPK3	1.24e-03	7	230	2	DOID:2870 (is_implicated_in)
Disease	branchiootorenal syndrome (implicated_via_orthology)	EYA4 EYA2	1.24e-03	7	230	2	DOID:14702 (implicated_via_orthology)
Disease	Alcoholic Intoxication, Chronic	SRD5A2 GGH LILRA1 VWF GRM7 FYN CDH10 CDH12	1.27e-03	268	230	8	C0001973
Disease	glucose metabolism disease (implicated_via_orthology)	DGKB IGF1R TLR5	1.33e-03	28	230	3	DOID:4194 (implicated_via_orthology)
Disease	pulmonary hypertension (is_implicated_in)	VWF MAPK1 MAPK3	1.62e-03	30	230	3	DOID:6432 (is_implicated_in)
Disease	helping behavior measurement	USH2A TMEM33	1.64e-03	8	230	2	EFO_0008538
Disease	disease recurrence, malaria	UROC1 PTPRT	1.64e-03	8	230	2	EFO_0001068, EFO_0004952
Disease	breast carcinoma (is_marker_for)	ESR1 SRD5A2 STK11 PLCG1	1.78e-03	66	230	4	DOID:3459 (is_marker_for)
Disease	temporal lobe epilepsy (biomarker_via_orthology)	GLUD1 GLUD2 FYN	1.79e-03	31	230	3	DOID:3328 (biomarker_via_orthology)
Disease	nicotine dependence symptom count	DGKB F3 NRXN1 CACNA2D1 ABI3BP NBEA CSMD1 CDH12	1.87e-03	285	230	8	EFO_0009262
Disease	intestinal cancer (implicated_via_orthology)	SOX14 FRK FYN	1.96e-03	32	230	3	DOID:10155 (implicated_via_orthology)
Disease	reading and spelling ability	OTOL1 UROC1 SEMA6D NRXN1 CACNA2D1 ELAVL2	1.98e-03	166	230	6	EFO_0005301
Disease	aspartate aminotransferase measurement	EYA4 CACNA2D2 SRD5A2 EYA2 B4GALT1 CDH20 RHOBTB2 FECH DNMBP SLC26A2 DNAH2 PKD2L1 WDR91 FRK CD36 CSMD1	2.06e-03	904	230	16	EFO_0004736
Disease	ureteral obstruction (implicated_via_orthology)	MAPK1 MAPK3	2.10e-03	9	230	2	DOID:5199 (implicated_via_orthology)
Disease	joint hypermobility measurement	ARHGAP44 COL12A1 ABI3BP	2.15e-03	33	230	3	EFO_0007905
Disease	Adenocarcinoma	ESR1 STK11 HSPD1 FAT4 GPX3	2.19e-03	116	230	5	C0001418
Disease	Carcinoma, Granular Cell	ESR1 STK11 HSPD1 FAT4 GPX3	2.19e-03	116	230	5	C0205644
Disease	Adenocarcinoma, Tubular	ESR1 STK11 HSPD1 FAT4 GPX3	2.19e-03	116	230	5	C0205645
Disease	Adenocarcinoma, Oxyphilic	ESR1 STK11 HSPD1 FAT4 GPX3	2.19e-03	116	230	5	C0205642
Disease	Carcinoma, Cribriform	ESR1 STK11 HSPD1 FAT4 GPX3	2.19e-03	116	230	5	C0205643
Disease	Adenocarcinoma, Basal Cell	ESR1 STK11 HSPD1 FAT4 GPX3	2.19e-03	116	230	5	C0205641
Disease	pulse pressure measurement, alcohol drinking	PRDM8 HOXC6 FES ADAMTS8	2.20e-03	70	230	4	EFO_0004329, EFO_0005763
Disease	platelet-to-lymphocyte ratio	HDAC9 ITGA4 PTPN4 PLEC VWF TMC4 RCL1 CD69 LTA	2.30e-03	363	230	9	EFO_0008446
Disease	glucagon-like peptide-1 measurement	COL12A1 CSMD1	2.61e-03	10	230	2	EFO_0008465
Disease	hydroxyproline measurement	PTPRT CSMD1	2.61e-03	10	230	2	EFO_0010498
Disease	Uterine leiomyoma, estrogen-receptor negative breast cancer	POGLUT3 ESR1	2.61e-03	10	230	2	EFO_1000650, HP_0000131
Disease	cortical thickness	HDAC9 RELN EYA4 LAMA1 CUL9 CDH20 PLEC HSPG2 FBXW10 SFRP1 COL12A1 LAMA2 GLOD4 ADAMTS8 TG IGF1R ELAVL2 MAPK3	2.93e-03	1113	230	18	EFO_0004840
Disease	coronary artery calcification	ENPP3 COQ2 SEMA6D DNAH6 CACNA2D1 ABI3BP SLC35B3 MED13L GRM7 CDH12	2.96e-03	450	230	10	EFO_0004723
Disease	Nonsyndromic genetic hearing loss	EYA4 PTPRQ FOXI1 TECTA	2.98e-03	76	230	4	cv:C5680182
Disease	interleukin 18 measurement	RELN SRD5A2 LILRB1 PTPRT	2.98e-03	76	230	4	EFO_0004581
Disease	Developmental delay (disorder)	CACNA2D2 DEGS1 IGF1R	2.99e-03	37	230	3	C0424605
Disease	cell growth regulator with EF hand domain protein 1 measurement	NID1 NID2	3.18e-03	11	230	2	EFO_0801461
Disease	guanosine diphosphate measurement	BAZ2B NBEA	3.18e-03	11	230	2	EFO_0010494
Disease	cryptorchidism (biomarker_via_orthology)	ESR1 IGF1R	3.18e-03	11	230	2	DOID:11383 (biomarker_via_orthology)
Disease	endometrial adenocarcinoma (is_marker_for)	MAPK1 MAPK3	3.18e-03	11	230	2	DOID:2870 (is_marker_for)
Disease	Liver Cirrhosis, Experimental	SRI GGH SEMA6D AGL NID1 OTULINL NID2 COL12A1 VWF BIRC3 NBEA CD36 FYN SEZ6	3.19e-03	774	230	14	C0023893
Disease	platelet measurement	HDAC9 EPPK1 PLEC VWF SLFN12L CD36 RCL1 KCTD20	3.45e-03	315	230	8	EFO_0005036
Disease	Cardiomyopathies	HSPD1 DSC2 LAMA4 MAPK1 MAPK3	3.58e-03	130	230	5	C0878544

Protein segments in the cluster

Peptide	Gene	Start	Entry
YQDLGIPVLNSAAGY	ARID4B	366	Q4LE39
AINYTEPFVIYLGLN	ARSK	191	Q6UWY0
PYVQYFGGVSALSKQ	B4GALT1	281	P15291
NYNGYVAGIPNSLVT	ADAM5	61	Q6NVV9
PIALQFGAYSAYTQA	CELF3	196	Q5SZQ8
REDNLYYGNLGIVPS	CATSPERD	311	Q86XM0
VILSPGYPGNYFNSQ	CSMD1	2331	Q96PZ7
GVILSQSYPGSYPQF	CSMD2	2366	Q7Z408
VYYYNQGTLGPQLSC	C2orf78	211	A6NCI8
RLTPNYTLGANGYVF	CACNA2D2	536	Q9NY47
GINYALGTNVSYPNN	B4GAT1	196	O43505
LPHNFRVYSYSGTGI	ADAM2	66	Q99965
YGYNDIVTIPAGATN	ADAMTS8	701	Q9UP79
NFGGRLQGEVAYYAP	BAZ2B	761	Q9UIF8
LPQNFLVYTYNETGS	ADAM18	66	Q9Y3Q7
YTKLGYAGNTEPQFI	ACTR3B	16	Q9P1U1
FVNVASYUGLTGQYI	GPX3	66	P22352
SYUGLTGQYIELNAL	GPX3	71	P22352
FLQGSYTRGIDPNYA	FBXW10	331	Q5XX13
TVEIFVNYYGNLFPG	FAT4	3616	Q6V0I7
YFYPQSLVSNLDPGA	BARHL1	261	Q9BZE3
AFVLYNNLGPYLSTE	ADGRL3	731	Q9HAR2
GVTYTVPVFQGYNLL	ACTL9	201	Q8TC94
VNPEQLASAGFYYVG	BIRC3	271	Q13489
TRAYYGNINFFGGPS	POLE2	251	P56282
TYGVALYRFQALEPN	DNMBP	246	Q6XZF7
RGYISPYFINTSKGQ	HSPD1	221	P10809
EYVTFNGSYLLDGNP	ANKRD12	1866	Q6UB98
NYTIYYSIRGPGVDQ	DSC2	166	Q02487
GHAIITNYLLNYFPG	ANKRD33B	166	A6NCL7
GKNSFRGQLQVYTYP	CNTN5	376	O94779
INQTGTTLYYQPGLL	RCL1	66	Q9Y2P8
TGILSPRGDDYFNYN	RANBP2	951	P49792
GGYGYAVQQPITAAA	RBM24	191	Q9BX46
YNGDPEGALIQFATY	RBM26	566	Q5T8P6
NGILTFSNLSPGQYY	NOMO3	911	P69849
LYIFQASPADAGQYV	HSPG2	2296	P98160
NLSGYLSDYSFIPNQ	PTPN4	166	P29074
AYIGTQGPLENTYRD	PTPN9	371	P43378
RYFPGQLNYLGSSHQ	PAQR3	261	Q6TCH7
NTKFTSQPGYIGRLY	MAMDC2	386	Q7Z304
FLQGSYTRGIDPNYA	FBXW10B	331	O95170
LSVGQYNCPGQYTFS	CD69	61	Q07108
QYVYNLVPRGQYTSG	MCM4	521	P33991
GQVFDVGPRYTNLSY	MAPK1	16	P28482
GPYTLDRNSLYVNGF	MUC16	12491	Q8WXI7
SPYFGINQTTGALYL	DCHS1	2856	Q96JQ0
SLVGVNSGQTAPYYA	COQ2	291	Q96H96
NSGQTAPYYAALGAV	COQ2	296	Q96H96
QPFQGQLSGLYYNGL	NRXN1	256	P58400
NGILTFSNLSPGQYY	NOMO2	911	Q5JPE7
VSPYGLNGTLTGQAY	MED13L	211	Q71F56
FGINSILYQRGIYPS	MAD2L1	26	Q13257
TPYGNQTDYRIFELN	LDB1	61	Q86U70
PFENGQYLDIYGITR	NEGR1	181	Q7Z3B1
GLGNPQDVTYFVAYQ	IFNLR1	46	Q8IU57
YNLTGLQPFTEYVIA	IL31RA	186	Q8NI17
GGYKFYLQNRSLPQS	GLOD4	136	Q9HC38
GGRSEVIYNYVQRPF	KCTD20	336	Q7Z5Y7
PILFNNLDVNYGASY	MMRN1	1116	Q13201
FENQYYPNGIRLTSS	IQSEC1	816	Q6DN90
TNTEGVNKGIYFSYP	CCDC178	66	Q5BJE1
RLGNGVLYASVNPEY	IGF1R	966	P08069
GIYAYGFEKPSAIQQ	EIF4A1	46	P60842
LYGSAITLNGDQDPY	AK8	446	Q96MA6
AAANAQVYGQTGLPY	ESR1	66	P03372
YFTYIPENNARGASI	PCDHGA10	461	Q9Y5H3
PGVIYSQTAVENYGS	PECR	201	Q9BY49
ALEGLQYPFAVTSYG	NID1	1146	P14543
GNTYALYVRDTLQPG	CUL7	366	Q14999
GPQVYITTNGAVYIL	FAM234B	316	A2RU67
DQGRPFQGQVSGLYY	NRXN2	1301	Q9P2S2
NGILTFSNLSPGQYY	NOMO1	911	Q15155
VQLRNGLPYFSYDLG	LAMA2	2816	P24043
PSVINSANYVYFLGL	GGPS1	86	O95749
FDVGPRYTQLQYIGE	MAPK3	36	P27361
RNPDLIQAGYYSFGL	NLRP2	546	Q9NX02
GEYGYLGQPNAVRTN	HOXA1	221	P49639
QPFQGQLSGLYYNGL	NRXN1	1261	Q9ULB1
EGGPLLYENITFVYN	P3H2	441	Q8IVL5
SLGYAYINFQQPADA	PABPC1L	51	Q4VXU2
TLPYFYGNVGDIVVS	GREB1L	406	Q9C091
LAFQTYTIYRPGSEG	NEK3	426	P51956
QQYSFGPEKYTGSNV	OTULINL	181	Q9NUU6
QSLGFYLGNVQPYCG	RELN	881	P78509
YDLTLQGPNENYSFI	PTPRQ	1226	Q9UMZ3
TQPFTVGDNKTYNGY	PTPRT	676	O14522
YGYDPLQRQSLFGAQ	HOXB8	86	P17481
GAAVAQNRIYSTPFY	HOXC6	41	P09630
IPNQGYLSEAGAYLV	PI4K2B	181	Q8TCG2
VGTFLLYTQGQQIGY	NID2	1106	Q14112
QGRPFQGQVSGLYYN	NRXN2	256	P58401
IVGNSGLNIYNLYAP	CTSA	266	P10619
PTAFLAQALYSYTGQ	FCHSD1	546	Q86WN1
VYTTQPGVQFYTGNF	GALM	271	Q96C23
GSSQQLQGYIPSNYV	FRK	91	P42685
LGPFTGQYRTVLYDS	DNAH1	3161	Q9P2D7
YQGFGVSVQGIIVYR	SLC25A31	186	Q9H0C2
YTKLGYAGNTEPQFI	ACTR3	16	P61158
RYGYNNVVTIPAGAT	ADAMTS4	696	O75173
SAGYVPVYLNFSAQT	DNAH6	2116	Q9C0G6
LYSLGGAFPIENIYS	EYA4	561	O95677
GTRFSNGPQSYQYLI	IGSF10	2376	Q6WRI0
APGRYDIFQYQATNG	GRM6	466	O15303
QKYRITYQPSTGEGN	COL12A1	1781	Q99715
QTTFTATRPGVYYGQ	MT-CO2	181	P00403
LIYQFSPIYTGNISS	GGH	296	Q92820
ARVIYSILQGQPYFS	CDH10	196	Q9Y6N8
QVFGSATGLARYYPA	CACNA2D1	206	P54289
SRGQYYGGSLPNVNQ	CRTC1	56	Q6UUV9
NGVNVVSGPIFDYNY	ENPP3	741	O14638
GQFYAGLSAESYPII	EPM2AIP1	526	Q7L775
QTGGYGLEYQQPFFE	ENTR1	151	Q96C92
ARVVYSILQGQPYFS	CDH20	201	Q9HBT6
PDLYLNAGGVTVSYF	GLUD1	426	P00367
TTVGLFYPYNNTADG	CD36	196	P16671
GGYYITTRAQFETLQ	FYN	211	P06241
NLPQGVRYIYTIDGS	DCX	96	O43602
YGQSFCQGSTGLLPY	AWAT1	256	Q58HT5
YLLNPRQVYSLSGNG	DGKB	461	Q9Y6T7
YGPLNLLTFNVGYHN	DEGS1	246	O15121
TGQSLGYGFVNYIDP	ELAVL2	76	Q12926
ALLYQGPHNTLFGYS	ITGA4	41	P13612
AAGGVLLDNYYTQPL	ARSB	76	P15848
QAGIVPNTITYGYYN	DENND4B	841	O75064
GDAPGRYDIFQYQTT	GRM7	471	Q14831
SRSGYGEYVQQTLQP	CUL9	371	Q8IWT3
ARVVYSILQGQPYFS	CDH12	196	P55289
YNSVNTSGVLYPREG	FOXI1	361	Q12951
TVQYGVHGNFPRLSY	HLTF	16	Q14527
RTLATGYQYSFPELG	SDR39U1	271	Q9NRG7
GTQQAFYNDPSVLYI	HDAC5	876	Q9UQL6
GLERAIAFTQYPQYS	FECH	181	P22830
GTQQAFYADPSILYI	HDAC9	826	Q9UKV0
RAGSFFYPGGNVTYQ	ENPP7	136	Q6UWV6
FYPGGNVTYQGVAVT	ENPP7	141	Q6UWV6
NYFLVGPYTEQGVRT	GYS1	61	P13807
TSVYPGAYNAFQIRA	EFEMP2	366	O95967
YAGFGPEYEITQSLV	ZMPSTE24	111	O75844
NYEYLGNSGRLVITP	DNAH2	1766	Q9P225
AFTVYNGELLYGSPA	PRDM13	461	Q9H4Q3
VNEPLAAYSYFQIGA	ATP4A	856	P20648
PDLYLNAGGVTVSYF	GLUD2	426	P49448
VVGSRSYQYQVQGFP	HELB	96	Q8NG08
NYRFLSNGYIPIPGQ	MYH10	306	P35580
LLTGVNRAYPYSQTG	CEBPZ	486	Q03701
AGFFPQLRYQVGNTY	FAM166A	21	Q6J272
NFTLGPVSRSYGGQY	LILRA3	281	Q8N6C8
LYNDQGNYSPVTGKF	OTOL1	366	A6NHN0
LQSGRIGLYPANYVE	PACSIN3	406	Q9UKS6
PYNLYAEQLSGSAFT	HGD	36	Q93099
LQPNGLLFYYASGSD	LAMA4	1266	Q16363
YGLGSVFPIENIYSA	EYA2	461	O00167
QPEAEYQGFLRQYGS	FES	256	P07332
QGYQTYGHFPSRAIK	NR5A2	256	O00482
YGAYNTSAFGIELLP	RNF139	106	Q8WU17
GNIYSGLPDYSVSFL	AK9	346	Q5TCS8
GNQRYEALVPGSINY	AK9	1736	Q5TCS8
TGIFYVDPVGNNYTL	USH2A	2366	O75445
AGLQGLTIYFYNSNR	STAP2	41	Q9UGK3
GSLVYLRQGIENSPY	RMND5A	236	Q9H871
CLLVNLYPGNQGYSV	SUPT20HL1	76	Q3ZLR7
SNLYGSPGSIYIRQT	TAB3	221	Q8N5C8
DSFYRSSYPQQQGLG	TBX5	351	Q99593
NFTLGPVSRSYGGQY	LILRA1	281	O75019
NFTLGPVSRSYGGQY	LILRB1	281	Q8NHL6
QGVYYSPQVGNFSKA	NKX6-3	86	A6NJ46
QYGYNVAAVNSPALL	SLC2A5	31	P22732
NLRGTTEGVYYQAPD	LAMA1	1186	P25391
IAGRTYNDLNQYPVF	NBEA	2306	Q8NFP9
TPQQYRASGSYFGLE	PRDM8	351	Q9NQV8
TGYTEQLQQYSSPGL	EPHB6	626	O15197
LTGYKFQPTGNNPYL	GPR108	491	Q9NPR9
RAVTGYTDPYTGQQI	EPPK1	686	P58107
YTDPYTGQQISLFQA	EPPK1	691	P58107
GYTDPYTGQQISLFQ	EPPK1	1651	P58107
RAVTGYTDPYTGQQI	EPPK1	2841	P58107
YTDPYTGQQISLFQA	EPPK1	2846	P58107
GYTDPYTGQQISLFQ	EPPK1	3376	P58107
RAVTGYTDPYTGQQI	EPPK1	3906	P58107
YTDPYTGQQISLFQA	EPPK1	3911	P58107
TGYTDPYTGQQISLF	EPPK1	4976	P58107
SDYINANFIKGVYGP	PTPN12	86	Q05209
LGIPYYETSVVAQFG	RHOBTB2	181	Q9BYZ6
GNPSVGIFYFVSYII	SCN9A	1731	Q15858
NTSLGYLNYPTQVIF	SLC35B3	161	Q9H1N7
AGVTLYNITTGLYPF	STK11	241	Q15831
YNITTGLYPFEGDNI	STK11	246	Q15831
QISTRLPSEYIYGFG	SI	1101	P14410
YVSFQSDIGPYQSGR	SFRP1	36	Q8N474
GLSYPQGYSLASGQL	ARHGAP44	691	Q17R89
QFELLNYTPADYGGL	MTRF1	221	O75570
CLLVNLYPGNQGYSV	SUPT20HL2	76	P0C7V6
QPEQLASAGFYYVGR	BIRC2	286	Q13490
QGLQFVYLSFVYPND	B4GALNT4	361	Q76KP1
YTPLSLAASGGYVNI	ANKHD1	1156	Q8IWZ3
SLAGTYLNYLGPPFN	CLCF1	56	Q9UBD9
GQGQQYGSYRAPQTA	SS18L1	361	O75177
PYRTVYVNNNGVVSF	TECTA	61	O75443
PVRYFYLQAVNSEGQ	POGLUT3	46	Q7Z4H8
IQLSTGYQAPYFLTV	PLPPR4	196	Q7Z2D5
NNSLLVPTSGIYFVY	LTA	96	P01374
FPVLNVTRYYNANGD	ZMYND19	141	Q96E35
YQDGNLVIQFPGLYF	TNFSF8	126	P32971
FVGGLPLAYQQTSAF	TMEM175	351	Q9BSA9
LGLTAIQTQNPGFYY	TRAPPC11	336	Q7Z392
TTIYELGPNYVGSFQ	WDFY3	1281	Q8IZQ1
YVLVQDYCGSNPGTF	VWF	891	P04275
PQYVSAFANTDGGYL	SLFN12L	241	Q6IEE8
LYPNEFVNYTGASIL	SLITRK5	96	O94991
LLAGQEPVYGLYTSF	SLC26A2	131	P50443
ILLYFPNGQTSYASS	TM4SF18	26	Q96CE8
NGGYYPVQLSFTEAQ	UROC1	351	Q96N76
YNEATGGNYVPRAVL	TUBB4A	51	P04350
GVNYLPSIFIAGVNF	TMC4	391	Q7Z404
PGAAQGIQFYLYPNL	SLC6A13	256	Q9NSD5
TSYRQTGLAPGQEYE	TNC	766	P24821
TSYVLRGLEPGQEYN	TNC	1036	P24821
GNSYLSLYFSTGQNP	TTC5	186	Q8N0Z6
GQYSNSVFIRLYVSP	PHEX	196	P78562
GDITYGQFAQLYRSL	PLCG1	206	P19174
ISYRIPQGGLFTYVS	SRD5A2	176	P31213
YQCYPGYQVVGSSVL	SEZ6	736	Q53EL9
QDPGLGLQLIYYSFD	TRBV24-1	56	A0A075B6N3
QALGQGPEFLTYFNY	TRBV7-6	56	A0A1B0GX31
QALGQGPEFLTYFNY	TRBV7-7	56	A0A0K0K1E9
GIYYVGIYSSSLQQP	SLAMF7	101	Q9NQ25
ETFGQYPLQVNGYRN	USP28	311	Q96RU2
GYRDPYTGQSVSLFQ	PLEC	3241	Q15149
GVYLPGSRQTLSIYQ	PLEC	3831	Q15149
VIDSSGYVNPNYTGR	PIGR	176	P01833
QTYLARVFSYPAGNV	F3	101	P13726
NANRILGPAYFVTYV	PKD2L1	531	Q9P0L9
SPVNGYFGGSLYARQ	TM9SF3	336	Q9HD45
GVETPSQNRYVGYFA	TPTE2	366	Q6XPS3
YYPQVSFGISANTFL	VN1R17P	16	Q8TDU5
LGYGSNVSPNQYFPL	ABI3BP	61	Q7Z7G0
NLLGELYSSNFYGLP	TLR5	346	O60602
AFLGSVPQLTYQLYV	XKRX	176	Q6PP77
GPYQNYTVIFVGSEA	SEMA6D	431	Q8NFY4
GPFVLSGYSGYKQVQ	WDR91	651	A4D1P6
ILNGQLSQYPGSYSD	TG	871	P01266
FIGGITAPTVRQYYA	PTDSS1	326	P48651
TQDPLYGYFAAVAGQ	SRI	31	P30626
TGALPYASTLGYQNG	SOX14	161	O95416
FSGQGSLLQPFIYYR	TMEM33	176	P57088
TQVPGYGNYELTFES	ZNF214	111	Q9UL59
ADFRNYQYTLPVVQG	ZFYVE9	1111	O95405
YGVGSYREVNPALFT	ATP6V0A2	386	Q9Y487
GPTLQGKAVTVYTNY	AGL	36	P35573
GVRQVLYGDLLSQYP	KCNF1	31	Q9H3M0
YIDIYFNPSGVIEGA	MYO7B	216	Q6PIF6
QPLVNTYAIAGYNAT	MYBPC1	1051	Q00872